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Abstract 
 
Research on exposure to animals and risk of type 1 diabetes (T1D) has had 
conflicting results with some researchers finding that animal exposure reduces the risk of 
T1D and others finding no association between animal exposure and T1D. Previously 
conducted studies on the association between animal exposure and T1D are case-
control studies that have been limited by recall bias. The purpose of this study is to 
investigate the association between early life animal exposure and the risk of persistent, 
confirmed islet autoantibodies (IA) and T1D diagnosis among an eligible cohort of 
genetically high T1D risk participants enrolled in the international prospective cohort 
study, The Environmental Determinants of Diabetes in the Young (TEDDY). It is 
hypothesized that children who are exposed to animals in early life will have a lower risk 
of developing IA and T1D than children who are not exposed to animals in early life.   
A total of 7,432 TEDDY participants were included in the study. The associations 
between early life animal exposure and the outcomes of interest were explored using 
Cox proportional hazards models. In order to control for confounding, a propensity score 
analysis was applied by three different methods: adjustment for the propensity score 
variable in the Cox proportional hazards model, stratification on propensity score groups, 
and propensity score pair matching.  
Early life animal exposure was not associated with diabetes autoimmunity or T1D 
onset in this genetically high T1D risk population. These findings were consistent across 
all three propensity score analysis methods and when directly adjusting for HLA type. 
The hypothesis that children who are exposed to animals in early life will have a lower 
vii 
risk of developing IA and T1D than children who are not exposed to animals in early life 
is not supported by this study.   
The results of this study suggest that there is no association between early life 
animal exposure and development of T1D. Performing this analysis again after longer 
follow-up has been completed for the study population is recommended as it may 
elucidate the effect of animal exposure on T1D and IA risk. Further studies are also 
needed on animal exposure and T1D in different types of environments (e.g., high 
residential density) and the effect of different types of animal exposures (e.g., species, 
duration) on T1D and IA risk. Additionally, studies on differences in perceptions of pets 
across countries could also aid the interpretation of studies on animal exposure and 
health outcomes. 
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Introduction 
Background 
  Type 1 diabetes (T1D) is a chronic disease characterized by the autoimmune 
destruction of pancreatic beta-cells leading to absolute insulin deficiency (1). Insulin is a 
hormone produced by the pancreatic beta-cells to lower the glucose level in the body 
and is essential for survival. Uncontrolled glucose levels can result in complications such 
as diabetic ketoacidosis, retinopathy, neuropathy, and nephropathy (1). There is 
currently no standard practice available to prevent or cure T1D. The standard treatment 
for T1D is multiple daily injections of insulin through a pump or needle and patient self-
monitoring of blood glucose with the challenging goal of obtaining and maintaining 
glycemic control. The onset of T1D is known to occur early in life with three-quarters of 
all individuals with T1D diagnosed under the age of 18 years (1).  
The incidence of T1D has increased over time. A study assessing T1D incidence 
trends among Colorado youth enrolled in the Colorado IDDM Registry and SEARCH for 
Diabetes in Youth Study reported an annual increase in T1D incidence of 2.3% (95% CI: 
1.6-3.1) from 1978 to 2004 (2). The EURODIAB study, an international collaborative 
effort consisting of 20 population-based registries across 17 countries, reported a 3.2% 
(95% CI: 2.7-3.7) annual increase in T1D incidence from 1989 to 1998 and a 3.9% (95% 
CI: 3.6-4.2) annual increase from 1989 to 2003 (3, 4). The DIAMOND project, an 
international collaborative effort across 57 countries, reported an annual increase of 
2.4% (95% CI=1.3-3.4) from 1990 to 1994 and an annual increase of 3.4% (95% CI: 2.7-
4.3) from 1995 to 1999 (5). T1D incidence is predicted to continue to increase, with the 
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incidence in children under 5 years of age predicted to double between 2005 and 2020 
(4, 5).   
Understanding why the incidence of T1D is increasing and what factors trigger 
the chain of reactions that cause the body to attack its own pancreatic beta-cells are 
among the many unanswered questions about T1D. Studies on the relationship between 
genetic disposition and T1D have reported associations between several genes and T1D 
risk, most notably human leukocyte antigens (HLA); however, less than 10% of 
genetically susceptible individuals actually develop T1D (6, 7, 8). Additionally, the 
pairwise concordance rate of monozygotic twins has been reported at 39% to 50% (9). 
These findings imply that genetics alone is not responsible for T1D risk and 
development. Reports of large T1D incidence variation across countries (5, 8), incidence 
increases too rapid to be explained by shifts in genetic susceptibility (5, 10), and reduced 
frequency of high risk HLA genotypes (11, 12) have led researchers to suspect that 
environmental exposures play a significant role in disease incidence. Thus, the question 
has been raised as to which environmental exposures play a role in triggering the 
autoimmune response leading to the destruction of beta-cells in the pancreas and 
development of T1D.  
Interest in environmental exposures and autoimmune disease development is 
rooted in the hygiene hypothesis, also known as the old friends hypothesis. The hygiene 
hypothesis is the assumption that individuals who are not exposed to organisms early in 
life that help to develop appropriate immunoregulation are more susceptible to 
autoimmune diseases as the immunoregulation deficit is believed to potentially cause an 
overreaction to later environmental exposures and attack important cells, such as the 
beta-cells critical to insulin production (13). Environmental exposures assessed in 
studies of the hygiene hypothesis and autoimmune disease development include 
elements that could lead to earlier and more antigenic exposure in life such as the 
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number of individuals in the household, number of siblings, room sharing, social contact 
(e.g., daycare, class size), geographical location (e.g., rural, urban), and animal contact. 
Researcher Graham A. W. Rook has identified several critical organisms that 
have an important contribution to immunoregulation and are relevant to chronic 
autoimmune disorders. Specifically, Rook has proposed Helicobacter pylori, Salmonella, 
and many species of helminths as protective against allergies, Hepatitis A virus and 
Necator americanus as protective against asthma,  and coxsackievirus B and rotavirus 
as protective against T1D (13). These particular organisms were selected because they 
were each abundant during mammalian evolution, are virtually absent from the present 
environment, and have had therapeutic effects in animal models or human clinical trials 
on chronic inflammatory disorders (13).   
The hygiene hypothesis has been repeatedly supported in studies of 
autoimmune diseases such as asthma and allergies (14, 15, 16). Strachan noted in his 
10-year review of epidemiological literature on the hygiene hypothesis that the scientific 
community has consistently found a higher prevalence of hay fever, eczema, skin prick 
positivity, and allergen specific IgE among individuals raised in smaller, more affluent 
families (15). Another example of evidence for the hygiene hypothesis is the case-
control study conducted by Boneberger et al. to test the validity of the hygiene 
hypothesis in regard to childhood asthma, which showed that daycare attendance (OR: 
0.31, 95% CI: 0.10-0.94) and regular farm animal contact (OR: 0.38, 95% CI: 0.17-0.85) 
in the first year of life had a statistically significant protective effect on childhood asthma 
(16).  
There is also evidence supporting a protective association between several of 
the environmental exposures related to the hygiene hypothesis and risk of T1D, 
including crowded living conditions, sharing a room, having older siblings, and social 
contact with other children (17, 18); however, minimal research has been conducted on 
4 
the relationship between animal contact and T1D risk specifically. The few studies that 
have assessed the relationship between animal contact and T1D risk have had 
conflicting results and notable design flaws. Marshall et al. conducted a matched case-
control study in Lancashire and Cumbria, United Kingdom to identify environmental risk 
factors for T1D in children up to age 16 years (17). Marshall et al. reported a statistically 
significant protective association (OR: 0.552, 95% CI: 0.309-0.987) between regular 
contact with pets or animals and the risk of developing T1D (17). Radon et al. conducted 
a case-control study in children age 6 to 16 years living in rural areas of Germany to 
explore the relationship between exposure to farming environments and T1D (19). 
Radon et al. reported no statistically significant associations related to regular contact 
with farm animals, defined as contact at least once per week, in the first year of life  (OR: 
1.2, 95% CI: 0.5-2.7) nor during the second to sixth year of life (OR: 0.81, 95% CI: 0.41-
1.6) (19). 
The major limitation of the previously conducted studies on animal contact and 
T1D is that exposure data was collected after T1D diagnosis, resulting in possible recall 
bias. Recall bias could result in overestimation of the association away from the null due 
to a systemic difference in the way that cases and controls recall the exposures of 
interest. For example, individuals diagnosed with T1D may be more cognizant of all 
environmental exposures and more likely to recall animal exposures than individuals 
who have not been diagnosed with T1D. An additional limitation of these studies is a 
possible lack of statistical power to detect weak effects due to sample size, as 
specifically noted by Radon et al. (19). Another general challenge of case-control studies 
is difficulty in selecting appropriate controls, which can result in selection bias and 
distortion of the reported measure of association. 
The Environmental Determinants of Diabetes in the Young (TEDDY) study is a 
multinational prospective cohort study with the primary goal of identifying environmental 
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exposures that contribute to increased risk of the development of beta-cell autoimmunity 
and T1D in genetically susceptible children from birth to 15 years of age (20). Among the 
vast amount of data collected as a part of the study is the report of pet and animal 
exposures by the primary caregivers of children followed in the study. The TEDDY study 
offers an ideal body of data for studying the relationship between animal contact and 
T1D risk as its study design allows for the collection of data on environmental exposures 
prior to T1D diagnosis, thereby limiting recall bias. Exploring the potential association 
between animal exposures and T1D without recall bias would greatly contribute to 
existing scientific knowledge on the hygiene hypothesis and T1D development.  
Another advantage of the cohort study design as opposed to the case-control 
study design is that multiple outcomes can be evaluated in cohort studies. This will allow 
for evaluation of both T1D diagnosis and pancreatic islet autoantibodies (IA), which are 
highly predictive of T1D risk and can be assessed prior to T1D diagnosis (21). An 
additional advantage of the TEDDY dataset is that it has a diverse international study 
population, which will allow possible effect modifiers such as country of residence to be 
evaluated and described. Data on possible confounders were also collected throughout 
the study; therefore, possible confounders can be controlled for when investigating the 
association between early life animal exposures and the risk of IA and T1D.  
 
Study Objectives 
In response to the minimal existing body of literature on the role of animal 
exposures in T1D development, the study design limitations of the existing literature, and 
the new possibilities and advantages offered by the TEDDY dataset, this study aims to 
investigate the association between reported early life animal exposures and T1D 
development, considering both persistent, confirmed IA and T1D diagnosis, among the 
8,677 individuals enrolled in the prospective international TEDDY cohort between 
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September 2004 and February 2010. Specifically, this study aims to answer the 
following questions: 
1. Does the risk of developing IA differ between children who are exposed to 
animals in early life and children who are not exposed to animals in early life? 
2. Does the risk of developing T1D differ between children who are exposed to 
animals in early life and children who are not exposed to animals in early life? 
 
Study Hypotheses 
It is hypothesized that children who are exposed to animals in early life will have 
a lower risk of developing IA than children who are not exposed to animals in early life. It 
is also hypothesized that children who are exposed to animals in early life will have a 
lower risk of developing T1D than children who are not exposed to animals in early life. 
These hypotheses are based on the assumption that animals increase a child’s 
exposure to organisms that help to develop appropriate immunoregulation and that 
children not exposed to organisms that help to develop appropriate immunoregulation 
are more susceptible to experience an autoimmune overreaction triggering the 
development of islet autoimmunity and T1D, as suggested by the hygiene hypothesis. 
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Methods 
Methods Overview 
The Environmental Determinants of Diabetes in the Young (TEDDY) Study is an 
international cohort study consisting of 8,677 participants at genetically high risk for type 
1 diabetes (T1D) who were enrolled as newborns between September 2004 and 
February 2010 and followed through the time of T1D diagnosis or age 15 years, 
depending on the time point encountered first for each participant. An abundance of data 
on environmental exposures that may contribute to increased risk of the development of 
IA and T1D are collected for each participant throughout study follow-up. Early life data 
and outcomes data on the TEDDY cohort will be used for the proposed study.   
The proposed observational study aims to investigate the association between 
early life animal exposure and development of IA and T1D using an eligible cohort of 
participants enrolled in the TEDDY study. Early life is considered to be prior to 9 months 
of age for the purposes of this analysis. This particular time period was selected, 
because the 9-month study visit is the first study visit at which animal exposure data is 
collected from TEDDY participants. Data on potential confounding variables will also be 
limited to early life exposure, before age 9 months. Propensity scores were incorporated 
into the analysis methodology to compare outcome risk between participants with similar 
animal exposure propensity scores and differing actual animal exposure status in order 
to control for confounding in the evaluation of the association between early life animal 
exposure and risk of IA and T1D. The propensity score calculated for each participant 
represents the predicted probability of early life animal exposure for that participant 
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based on other individual characteristics. Details on the study population, variables of 
interest, data preparation, and analysis methodology follow. 
 
TEDDY Study Overview 
TEDDY participants are recruited by six U.S. and European clinical centers 
located in Washington, Colorado, Georgia/Florida, Finland, Sweden, and Germany. The 
TEDDY data coordinating center is located at the University of South Florida in Tampa, 
Florida. The TEDDY study population to date includes children up to age 8 years who 
were enrolled in the TEDDY study during the screening period from September 2004 to 
February 2010. Newborns younger than 4.5 months of age who have high-risk HLA 
alleles in the general population (GP) or who have a first degree relative (FDR) with T1D 
were eligible for enrollment in the TEDDY cohort. The HLA alleles listed in Table 1 were 
considered high-risk alleles for the purposes of study screening. Newborns with an 
illness or birth defect that would prevent long term follow-up or would involve use of a 
treatment that may alter the natural history of diabetes were not eligible for enrollment. 
 
Table 1: Eligible HLA Haplotypes for TEDDY Study Enrollment 
HLA Haplotypes HLA Haplotype Category
DR4*030X/0302*DR3*0501/0201 DQ8/2 
DR4*030X/0302*DR4*030X/0302 DQ8/8 
DR4*030X/0302*DR4*030X/020X DQ8/8 
DR4*030X/0302*DR8*0401/0402 DQ8/4 
DR4*030X/0302*DR1*0101/0501 FDR 
DR4*030X/0302*DR13*0102/0604 FDR 
DR4*030X/0302*DR4*030X/0304 DQ8/8 
DR4*030X/0302*DR9*030X/0303 FDR 
DR3*0501/0201*DR3*0501/0201 DQ2/2 
DR3*0501/0201*DR9*030X/0303 FDR 
 
 
A total of 424,788 newborns were screened for the TEDDY study. Study 
screening involved HLA testing for HLA class II genes DRB1, DQA1, and DQB1. Parent 
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or primary caretaker consent was obtained from each potential participant prior to 
screening. Among the 418,367 GP newborns screened, 20,152 (4.8%) were eligible for 
enrollment. Among the 6,421 FDR newborns screened, 1,437 (22.4%) were eligible for 
enrollment. A separate consent was obtained from the parents or primary caretakers of 
eligible newborns prior to study enrollment. A total of 8,677 participants were enrolled in 
TEDDY as of February 2010.  
Newborns enrolled in the TEDDY study are followed until 15 years of age or T1D 
diagnosis, depending on which is encountered first. Follow-up study visits for exposure 
data collection occur quarterly (every three months) until age 4 years. The follow-up 
study visit schedule then continues biannually for participants who are negative for IA 
and quarterly for participants who are persistently positive for IA until age 15 years.  
 
Scope of Proposed Analysis: Animal Exposures, T1D, and Autoimmunity 
The purpose of this analysis is to explore the relationship between reported early 
life animal exposure reported at the 9-month study visit and the outcomes persistent, 
confirmed islet autoimmunity and T1D diagnosis among those eligible enrolled in 
TEDDY cohort (N=8,677) during the screening period. The exposure of interest is any 
exposure to animals prior to the 9-month study visit. Outcomes of interest include 
persistent, confirmed IA and T1D diagnosis. Data cleaning and statistical analyses were 
conducted using SAS version 9.2. 
 
Inclusion Criteria and Exclusion Criteria for Analysis 
Inclusion Criteria: 
1. Participant was enrolled in the TEDDY study between September 2004 and 
February 2010. 
2. Participant has a 9-month study visit record. 
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Exclusion Criteria: 
1. HLA results are pending or HLA results indicate that the participant does not 
have a high risk allele. 
2. Participant was diagnosed with T1D prior to the 9-month study visit. 
3. Participant had persistent, confirmed IA prior to the 9-month study visit. 
 
Of the 8,677 participants in the TEDDY cohort, 7,604 participants had a 9-month 
study visit record. Differences between participants who withdrew from the TEDDY study 
within one year of enrollment and those who remained in the TEDDY study have been 
previously described by Johnson et al. (22). Significant predictors of early withdrawal 
identified by Johnson et al. include country of residence, young maternal age, no father 
participation, and female gender. Exclusions were performed on the 7,604 participants 
who met the defined inclusion criteria in the order listed above. As outlined in Figure 1, 
135 participants were excluded due to pending or ineligible HLA results and 37 
participants were excluded due to having persistent, confirmed IA prior to the 9-month 
visit. The final study population for the analysis included 7,432 participants. 
 
Animal Exposure Classification 
History of animal exposures was collected from the primary caregiver at the 9-
month follow-up visit using a questionnaire. Questions 15 and 16 on the questionnaire 
focused on animal exposures. Question 15 asked if there were any animals or pets in 
the TEDDY child’s house with the option to select “Yes” or “No” in response. If the 
caretaker completing the questionnaire indicated that there were animals or pets in the 
TEDDY child’s house, the caretaker was also prompted to indicate the type of pet in the 
TEDDY child’s house and the number of pets in the TEDDY child’s house. Question 16 
asked if the TEDDY child lives on a farm with animals or if there were animals that lived 
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outside of the child’s house with the option to select “Yes” or “No” in response.  
Additionally, the caretaker was prompted to indicate the type of animals that live outside 
of the TEDDY child’s house. The full 9-month questionnaire which includes the 
described questions on animal exposures is provided in Appendix 2.  
The animal exposure data collected on the 9-month questionnaire were used to 
create a variable indicating whether or not each participant had any exposure to animals, 
regardless of whether the animal lived inside or outside the house, prior to the 9-month 
visit. This variable was created as a binary variable with “1” indicating that the participant 
was exposed to at least one animal as of the 9-month visit and “0” indicating that the 
participant was not exposed to any animals as of the 9-month visit. A participant was 
coded as “1” for this variable if the caretaker answered “Yes” to question 15, answered 
“Yes” to question 16, or selected a type of indoor or outdoor animal. Otherwise, the 
participant was coded as “0”. 
 
Outcome Classification 
The study analysis was performed for two separate outcomes: persistent, 
confirmed IA and T1D. Since the maximum age of the study population is only 8 years, it 
is expected that the number of participants diagnosed with T1D may not be large 
enough to make appropriate association conclusions. Islet autoimmunity is highly 
predictive of T1D and usually occurs prior to T1D diagnosis (21); therefore, it is expected 
that analyzing the relationship between animal exposures and persistent, confirmed IA 
will allow for more confident conclusions at this stage.  
A power analysis was conducted using the program Power and Sample Size 
(PASS) 12 by the Lakatos method. For the outcome IA, it is estimated that early life 
animal exposure will need to be associated with IA at a hazard ratio (HR) of 1.4 or 
greater in order for the study to have 80% power (Table 2), which would allow the study 
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to have an 80% probability of rejecting the null hypothesis when it is false.  For the 
outcome T1D, it is estimated that early life animal exposure will need to be associated 
with T1D at a HR of 1.65 in order for the study to have 80% power (Table 3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Eligibility Flowchart 
 
Table 2: Power for IA Outcome, Alpha=0.05, N=8,677, 50% Exposed, 4 Years Accrual, 
Follow-up to Age 8 Years, 14% Loss, 5% Conversion 
HR Power 
1.30 0.62 
1.35 0.75 
1.40 0.85 
1.45 0.91 
1.50 0.96 
 
 
Participants in the TEDDY cohort 
(N=8677) 
1073 participants did not have a 9-month 
visit record 
Participants in the TEDDY cohort with 
a 9-month visit record (N=7604) 
135 participants did not have high risk 
HLA alleles or had pending test results  
Final Study Population 
 (N=7432) 
0 participants were diagnosed with T1D 
prior to the 9 month visit  
37 participants had persistent, 
confirmed IA prior to the 9 month visit 
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Table 3: Power for T1D Outcome, Alpha=0.05, N=8,677, 50% Exposed, 4 Years 
Accrual, Follow-up to Age 8 Years, 14% Loss, 2% Conversion 
HR Power 
1.60 0.78 
1.65 0.83 
1.70 0.88 
1.75 0.91 
1.80 0.94 
 
 
Persistent, Confirmed Islet Autoantibodies (IA) Outcome 
The persistent, confirmed IA outcome is defined as the presence of IA at two 
consecutive visits confirmed by two separate laboratories. TEDDY participants are 
screened for glutamic acid decarboxylase autoantibodies (GAD65), insulinoma-
associated antigen-2 autoantibodies (IA-2), and insulin autoantibodies (IAA) every 3 
months, starting at age 3 months. Samples are initially sent to one of two TEDDY 
Central Autoantibody Laboratories for testing depending on geographical residence: 
Barbara Davis Center (Aurora, Colorado) or University of Bristol (Bristol, UK). If the test 
result is positive for GAD65, IA-2, or IAA, the sample is sent to the second laboratory for 
confirmation. Participants who receive positive results from both laboratories are 
considered to have confirmed IA. The participant will also be tested at his/her next study 
visit 3 months later. If both laboratories again indicate positive results, then the 
participant is considered to have persistent, confirmed IA. Children who had a confirmed 
antibody-positive result and were diagnosed with T1D prior to or at their next study visit 
were also deemed to have persistent, confirmed IA. Only participants identified as 
having persistent, confirmed IA are considered to have developed the autoimmunity 
outcome for the purposes of this analysis.  
Two variables related to the persistent, confirmed IA outcome were created for 
this analysis. A binary variable was created to indicate whether the participant had 
developed persistent, confirmed IA throughout the course of study follow-up with “1” 
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indicating the participant had developed persistent, confirmed IA and “0” indicating that 
the participant had not developed persistent, confirmed IA.  A continuous variable was 
also created to indicate the time until the participant developed persistent, confirmed IA 
or was censored. For participants with the event of interest (development of persistent, 
confirmed IA), this time variable represents the number of days from participant birth to 
the date of the blood draw associated with the persistent, confirmed IA determination 
(event date). For participants without the event of interest (no persistent, confirmed IA), 
this time variable represents the number of days from participant birth to the date of the 
participant’s last antibody-negative specimen sample date (censor date).  
 
Type 1 Diabetes (T1D) Outcome 
The TEDDY Study recognizes T1D diagnosis if at least one of the following 
American Diabetes Association (ADA) criteria is met on two occasions (unless criterion 4 
is present, in which case a single occasion is sufficient for diagnosis): 
1. Casual (any time of day without regard to time since last meal) plasma 
glucose ≥ 200 mg/dL, if accompanied by unequivocal symptoms (i.e. polyuria, 
polydipsia, polyphagia, and/or weight loss) 
2. Fasting (no food or drinks except water for at least 8 hours) plasma glucose ≥ 
126 mg/dL 
3. 2-hour plasma glucose ≥ 200 mg/dL in oral glucose tolerance test 
4. Unequivocal hyperglycemia with acute metabolic decompensation (diabetic 
ketoacidosis) 
These criteria are defined on the TEDDY T1D diagnosis data collection form (Appendix 
2). Once a T1D diagnosis is established for a participant using this criteria, data is 
collected on the diagnosis (i.e., date of diagnosis, symptoms, lab results) and further 
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study follow-up is discontinued. The TEDDY definition based on ADA criteria was also 
utilized for the purposes of this analysis.  
Two variables related to T1D diagnosis outcome were created for this study.  A 
binary variable was created to indicate whether the participant had been diagnosed with 
T1D with “1” indicating the participant had been diagnosed with T1D and “0” indicating 
that the participant had not been diagnosed with T1D. A continuous variable was also 
created to indicate the time until the participant was diagnosed with T1D or was 
censored. For participants with the event of interest (T1D diagnosis), this time variable 
represents the number of days from participant birth to the T1D diagnosis date (event 
date). For participants without the event of interest (no T1D diagnosis), this time variable 
represents the number of days from participant birth to the date of the participant’s last 
visit date (censor date).  
 
Potential Confounders 
Potential confounders for the proposed analysis include: country of residence, 
age, sex, maternal education, HLA type, first degree relative with T1D status, smoking 
during pregnancy, drinking during pregnancy, illnesses/conditions during pregnancy, 
maternal age at birth, birth weight, exclusive breastfeeding, formula exposure, cow milk 
exposure, vaccination, social group exposure, and crowding (residence density).  
 
Potential Confounder Definitions 
Demographic variables including participant sex and maternal education level 
were collected during infant screening for the TEDDY study. Sex was classified as either 
male or female. Maternal education was collected at the 3-month study visit and 
classified as primary school through some trade school, graduated from trade school or 
some college/university education, or graduated from a college/university. Country 
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classification was based on where the clinical center which enrolled the participant was 
located (United States, Finland, Germany, or Sweden). Participant age was calculated 
as the number of days from the participant’s date of birth to the participant’s last study 
visit date.  
T1D risk characteristics including HLA testing results and first degree relative 
(FDR) status were collected during TEDDY study screening. Each participant was 
assigned to a HLA category based on the high risk allele identified during screening as 
outlined in Table 1. A separate variable for FDR status was coded to indicate whether or 
not the participant had a mother, father, and/or sibling who had been diagnosed with 
T1D, with “1” assigned to participants who have a FDR with T1D and “0” assigned to 
participants who do not have a FDR with T1D.  
 Prenatal exposures were collected from the TEDDY child’s mother at the 3-
month study visit. Whether or not the mother smoked during each individual pregnancy 
trimester was reported during the visit. This information was then recoded into one 
variable that indicated whether or not the mother had smoked at all during pregnancy 
with “1” assigned to participants whose mother had smoked at least once during 
pregnancy and “0” assigned to participants whose mother had not smoked at all during 
pregnancy. Drinking during pregnancy was coded into one variable for the analysis 
structured in the same manner as described for the smoking during pregnancy variable. 
Illnesses and conditions during pregnancy were reported by the mother at the 3-month 
visit as well. A binary variable was created from these data to indicate whether the 
participant’s mother reported at least one illness or condition during pregnancy, assigned 
as “1”, or whether the mother did not report any illnesses or conditions during 
pregnancy, assigned as “0”. Maternal age at birth was calculated from the mother’s date 
of birth and participant’s date of birth and utilized as a continuous variable. Birth weight 
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was collected during the 3-month study visit in pounds and ounces. The measurement 
was converted to grams and utilized as a continuous variable. 
 Breastfeeding, formula, and cow milk exposures were collected every 3 months 
beginning at the 3-month study visit. Exclusive breastfeeding data on exposure and 
duration were recoded into one variable to summarize the length of time each participant 
was exposed to exclusive breastfeeding with the following categories: no exclusive 
breastfeeding (includes participants who breastfed once in the hospital only), <3 months 
of exclusive breastfeeding, and ≥3 months of exclusive breastfeeding. Exclusive 
breastfeeding duration is defined as the period of time for which breast milk was the only 
source of nutrition for the TEDDY child with no other food or formula introduced during 
this period. Data indicating whether or not the participant had been introduced to any 
infant formula and the age at introduction was combined into one summary variable with 
the following categories: not introduced in the first 9 months of life, introduced at age <3 
months, introduced between age 3 months to <7.5 months, and introduced at age 7.5 
months to <9 months. Data on cow milk exposure, consumed as a drink or mixed into 
another food product, was summarized in the same manner as described for formula.  
Vaccination history was also collected every 3 months beginning at the 3-month 
visit. This data was compiled into one binary variable indicating whether or not the 
participant had ever received any type of vaccination. Participants for whom at least one 
vaccination was received in the first 9 months of life were coded as “1” and participants 
for whom no vaccinations were received in the first 9 months of life were coded as “0”. 
At the 9-month study visit, the primary caretaker was asked to report the number 
of children under the age of 18 years living in the TEDDY child’s household, the number 
of adults age 18 years and older living in the TEDDY child’s household, and the number 
of rooms in the TEDDY child’s home not including bathrooms, porches, halls, or 
balconies. A household crowding score representing residence density was calculated 
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for each participant from this information by dividing the total number of people in the 
household, adults plus children, by the number of rooms in the house. Additionally, at 
the same visit the primary caretaker was asked to identify which of the following 
residence types best describes where the TEDDY child lives: rural area, small 
city/village, suburb, or big city.  
Social group exposure data was collected from the TEDDY child’s primary 
caretaker every 3 months beginning at the 3-month study visit. Social group exposure 
was defined as regular (once a week or more) day care or other social gathering that 
included at least one other child, who is not a sibling, in addition to the TEDDY child. A 
binary variable was created to indicate whether the TEDDY child had been exposed to a 
social group in the first 9 months of life. Children for whom an early life (in the first 9 
months) social group experience had been reported were coded as “1” and children for 
whom an early life social group experience had not been reported were coded as “0”.  
 
Data Preparation for Statistical Analysis 
The dataset was reviewed for data entry errors to prepare the dataset for 
analysis. Crowding space (residence density) values were coded as missing if any of the 
variables included in the calculation (number of children, number of adults, or number of 
rooms in home) were reported as an inappropriate value (e.g., -3 rooms, -2 adults). 
Crowding space was coded as missing for a total of nine participants due to 
inappropriate values. No other data entry errors were identified.  
Skewness was calculated for each variable. The skewness measure indicates 
the degree and direction of asymmetry of the data distribution for a given variable. 
Crowding space was the only continuous variable with a skewness value greater than 
three standard deviations. To normalize the skewed distribution, participants were 
categorized as having a crowding score of less than or equal to 1 or greater than 1.  
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Missingness was assessed for each variable by reviewing the frequencies of 
values for each variable. All variables were missing less than 3% of values. Missing 
trends were further assessed by tabulating the number of missing variables of interest 
for each participant in order to determine if a few participants were missing the majority 
of the variables and to consider whether participants should be removed from the 
analysis due to a high number of missing variables. A total of 174 participants were 
missing one variable only, 65 participants were missing two variables, and two 
participants were missing three variables. Since participants were only missing three 
variables at most and very few participants were missing more than two variables, no 
participants were removed due to frequency of missing variables. 
 
Statistical Analysis 
Analysis Overview 
 The association between early life animal exposure and persistent, confirmed IA 
and the association between early life animal exposure and T1D were explored using 
Cox proportional hazards (PH) models. A propensity score analysis was applied to 
control for confounding when assessing the relationship between the exposure and 
outcomes of interest. Propensity scores, calculated by logistic regression, represent the 
probability of a participant being exposed to animals based on the other data collected 
on that participant. The propensity score analysis was applied in three different ways: by 
adjustment for the propensity score variable in the Cox proportional hazards model, by 
stratification on propensity score groups, and by propensity score pair matching. Details 
on the methods addressed in this brief overview follow.  
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Univariate Analysis 
Frequencies were tabulated for each variable in order to assess missingness and 
distribution by exposure status. Chi-square tests were performed on each categorical 
variable to determine whether the proportions for each variable were equal for the 
exposed and unexposed study groups. Chi-square test p-values of less than 0.05 
indicate a statistically significant difference in proportions by exposure status. T-tests 
were utilized to determine if the means of continuous variables were equal across the 
exposed and unexposed groups. T-test p-values of less than 0.05 indicate a statistically 
significant difference in the means of the tested variable by exposure status. Degree of 
correlation between variables and early life animal exposure status was also explored for 
the purpose of assessing multicollinearity.   
The association between early life animal exposure and each outcome of interest 
was first examined by Kaplan-Meier survival curves to determine if there was any 
difference in outcome risk by exposure status. The log rank test was performed to 
provide a quantitative value indicating whether there was a statistically significant 
difference in risk by exposure status. Log rank test p-values of less than 0.05 indicate a 
statistically significant difference between assessed survival curves.  
 
Logistic Regression for the Calculation of Propensity Scores 
Propensity scores allow for the investigation of the association between early life 
animal exposure and risk of IA and T1D by simulating a randomized controlled trial from 
the dataset. The propensity score is the probability of a participant receiving “treatment” 
based on that participant’s characteristics. In this case, the treatment of interest is early 
life animal exposure.  
An early life animal exposure propensity score was calculated for each study 
participant by stepwise logistic regression. The propensity score calculated for each 
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participant represents the predicted probability of early life animal exposure for that 
participant based on other characteristics of the participant. Early life animal exposure is 
considered the outcome and other covariates (e.g., sex, country of residence) are 
considered predictors when calculating the propensity scores. Logistic regression is 
appropriate for the analysis due to the binary structure of the outcome variable, early life 
animal exposure (1=animal exposure in first 9 months of life, 0=no animal exposure in 
first 9 months of life). Stepwise logistic regression was utilized so that all potential 
variables that may affect the probability of a participant having early life animal exposure 
can be considered and variables that do not affect the probability of a participant having 
early life animal exposure could be excluded with the overall goal being to determine the 
most effective set of variables for predicting the outcome. 
 Environmental and demographic characteristics that may affect the probability of 
one having early life exposure to animals were of interest for the logistic regression 
model. All covariates were included in the initial stepwise logistic regression model, with 
the exception of HLA and participant age at last visit. HLA is an indicator of genetic risk 
for T1D and was included in the survival analysis. Age at last visit is represented by the 
time to event (outcome or censoring) in the survival analysis. The regression model was 
set to require a significance level of 0.1 for entry into the model and a significance level 
of 0.1 to stay in the model. Propensity scores predicting early life animal exposure were 
calculated utilizing the final logistic regression model. 
The propensity score calculated for each participant was added to the dataset as 
a single continuous variable. Additionally, each study participant was assigned a quintile 
based on propensity score, ranging from quintile 1 with the lowest propensity scores 
(least likely to have early life animal exposure) to quintile 5 with the highest propensity 
scores (most likely to have early life animal exposure). Interactions between early life 
animal exposure and predictors in the final logistic regression model were assessed by 
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calculating the measure of association for early life animal exposure and each outcome 
of interest by predictor variable category. For example, for the early life vaccination 
variable the measure of association between early life animal exposure and IA was 
calculated among participants who received early life vaccinations and then separately 
among participants who did not receive early life vaccinations for comparison. 
 
Cox Proportional Hazards Analysis 
The risk of persistent, confirmed IA and T1D by early life animal exposure status 
was examined by Cox proportional hazards modeling. Cox proportional hazards 
modeling is a type of survival analysis. In a conventional sense, survival would be 
interpreted as the probability of death and time until death. In health outcomes research, 
survival can be applied to the probability of a health outcome (e.g., T1D diagnosis) and 
the time until the health outcome (e.g., the time from birth to diagnosis of T1D). In other 
words, we can use survival analysis techniques to calculate the instantaneous risk for an 
outcome. Advantages of using survival analysis methods include the ability to account 
for the differing periods of time each participant contributes to the study and the ability to 
analyze the effect of predictors on time to outcome in addition to whether or not the 
outcome occurred. The Cox proportional hazards model is considered a semiparametric 
method, because the distribution of the underlying hazard does not need to be known or 
assumed.  
The primary assumptions of the Cox proportional hazards model are that the 
hazards are proportional and independent of time and that censoring is independent of 
event occurrence. The proportionality assumption was tested by randomly simulating 
1000 empirical score processes, based on martingale residuals, that meet the 
proportional hazards assumption for the variable early life animal exposure in regard to 
each outcome of interest and then calculating a p-value representing the percent of 
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simulated paths which had extreme points exceeding the most extreme point on the 
observed path for the variable of interest. A resulting p-value less than 0.05 would 
indicate evidence against the proportional hazards assumption. 
The binary early life animal exposure variable indicating actual animal exposure 
status was included in each Cox proportional hazards model as the independent 
variable. The risk of T1D and persistent, confirmed IA for the exposed group compared 
to the unexposed group (which serves as the reference group) is reported as a hazard 
ratio (HR) and corresponding 95% confidence interval (CI) for each model. HRs equal to 
1 indicate that there is no difference in risk between the exposed and unexposed groups. 
The 95% CIs that include 1 indicate that the calculated HR is not statistically significant. 
An unadjusted Cox proportional hazards model was run on the entire study 
population for each outcome, including only early life animal exposure as the 
independent variable and the outcome (T1D or IA) as the dependent variable, to 
determine the risk of the outcomes by exposure status prior to adjusting for any 
confounders. The risks of T1D and IA by early life animal exposure were then further 
assessed by incorporating the propensity scores into the Cox proportional hazards 
models in three ways, as described in detail in the three following sections. 
 
Propensity Score Application 1: Adjusting for Propensity Score within the Cox 
Proportional Hazards Model 
 In order to measure the risk of persistent, confirmed IA by early life animal 
exposure status while controlling for confounding, a Cox proportional hazards model was 
created that included the binary early life animal exposure variable and the continuous 
propensity score variable as independent variables and the binary IA outcome variable 
as the dependent variable. The model was run on the entire study dataset and the 
resulting HR and 95% CI were reported. The same procedure was repeated for the T1D 
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outcome. A second adjusted model that included early life animal exposure, propensity 
score, and HLA was also created for each outcome and then run on the entire study 
dataset in order to control for HLA as a potential confounder in addition to propensity 
score. DQ8/8 was defined as the reference group for HLA. The HR indicating the risk of 
the exposed group compared to the unexposed group (the reference group) was 
reported along with the 95% CI for each model. 
 
Propensity Score Application 2: Stratification on Propensity Score Quintiles 
The effect of early life animal exposure on the risk of each endpoint (T1D and 
persistent, confirmed IA) was examined within propensity score quintiles in order to 
further explore the relationship between early life animal exposure and the endpoints of 
interest. This method provided the opportunity to examine the effect of early life animal 
exposure on T1D and IA risk in groups of participants with similar propensity for early life 
animal exposure. This allows one to control for differences within the study population by 
studying the association in homogenous groups of people (participants with similar 
propensity scores and therefore similarities in the characteristics included in the final 
logistic regression model used to calculate the propensity score).  
Two Cox proportional hazards models were run in each propensity score quintile 
to determine the risk of the outcome (persistent, confirmed IA or T1D diagnosis) among 
those actually exposed to animals within specified quintile compared to those not 
actually exposed to animals within specified quintile: 
1. An unadjusted Cox proportional hazards model for each outcome that 
included only early life animal exposure in the model. 
2. An adjusted Cox proportional hazards model for each outcome that included 
both early life animal exposure and HLA in the model. DQ8/8 was defined as 
the reference group for HLA. 
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Two sets of these models were created, one for the outcome T1D and one for the 
outcome persistent, confirmed IA. Therefore, a total of four different Cox proportional 
hazards models were run in each quintile. For each endpoint, Kaplan-Meier survival 
curves were plotted by propensity quintile and homogeneity of risk across propensity 
quintiles was assessed by log rank test. 
 
Propensity Score Application 3: Propensity Score Pair Matching 
Exposed and unexposed participants were pair-matched by propensity score in 
order to ensure that compared participants were as similar as possible in an effort to 
thoroughly tease out any potential association between early life animal exposure and 
the endpoints IA and T1D. Participants were matched using the greedy match macro 
available from Mayo Clinic (23) as described by Faries et al. (24). A difference in 
propensity score of up to 0.1 was permitted. Two Cox proportional hazards models were 
run, stratified by matched pair, to determine the risk of the outcome (persistent, 
confirmed IA or T1D diagnosis) among those actually exposed to animals in early life 
compared to those not actually exposed to animals in early life: 
1. An unadjusted Cox proportional hazards model for each outcome that 
included only early life animal exposure in the model, stratified by matched 
pair. 
2. An adjusted Cox proportional hazards model for each outcome that included 
both early life animal exposure and HLA in the model, stratified by matched 
pair. DQ8/8 was defined as the reference group for HLA. 
Two sets of these models were created, one for the outcome T1D and one for the 
outcome persistent, confirmed IA. Therefore, a total of four different Cox proportional 
hazards models were run on the matched dataset.  
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Results 
Descriptive Statistics 
A total of 7,432 TEDDY participants met the study eligibility criteria and were 
included in the final study population. Of this study population, 3,987 (54%) participants 
had been exposed to animals prior to 9 months of age and 3,445 (46%) participants had 
not been exposed to animals prior to 9 months of age. The study population overall, as 
well as broken down by exposure status, is described in Table 4.  
The proportions of sex, FDR, pregnancy conditions, maternal age, early life 
formula introduction, and early life vaccination categories were consistent between the 
exposed and unexposed study populations (p≥0.05); however, there were significant 
differences across exposure groups for other variables. Compared to the unexposed 
population, the exposed population included fewer mothers who had graduated college 
(p<0.0001), more mothers who had smoked during pregnancy (p=0.0005), more 
mothers who drank alcohol during pregnancy (p=0.003), more participants without an 
exclusive breastfeeding experience (p=0.0002), and more participants who were 
introduced to cow milk prior to 3 months of age (p=0.0003). Additionally, participants in 
the exposed group had a lower mean birth weight (p=0.008) and were slightly younger 
as of the last study visit (p=0.04) than participants in the unexposed group. 
Characteristics of the environment in which the participants lived, both in terms of 
crowding (residence density) and residence type, differed significantly between the 
exposed and unexposed groups (p=0.0003 and p<0.0001, respectively). The exposed 
group had a much higher percentage of participants who lived in a rural environment 
27 
(20%) than the unexposed group (8%). The exposed group also had fewer participants 
in a crowded environment (9%) than the unexposed group (11%). 
Additionally, country distribution was vastly different between the exposed and 
unexposed populations (p<0.0001). The most striking difference is the distribution of 
U.S. participants. The exposed group included 2,091 (52%) U.S. participants; whereas, 
the unexposed group included only 966 (28%) U.S. participants. Furthermore, the 
exposed group included fewer participants from Finland (15%), Germany (6%), and 
Sweden (27%) than the unexposed group which included 30%, 7%, and 35%, 
respectively. Distribution of HLA allele type also varied greatly between the exposed and 
unexposed populations (p<0.0001). Notably, there were more DQ8/4 allele types in the 
unexposed population (19%) than in the exposed population (15%), which is likely linked 
to higher prevalence of Finnish participants in the unexposed population, since the HLA 
DQ8/4 genotype is more prevalent in this TEDDY country-specific population (25). 
A total of 417 (6%) participants in the study population developed persistent, 
confirmed IA. Of these participants, 221 (53%) were exposed to animals early in life 
(prior to 9 months of age) and 196 (47%) were not exposed to animals early in life (Table 
5). The Kaplan-Meier survival curves detailing cumulative incidence of IA by early life 
animal exposure are shown in Figure 2. There is not a statistically significant difference 
between the survival curves for IA by early life animal exposure (p=0.92). 
A total of 113 (2%) participants in the study population were diagnosed with T1D. 
Of these participants, 59 (52%) were exposed to animals early in life and 54 (48%) were 
not exposed to animals early in life (Table 6). The Kaplan-Meier survival curves detailing 
cumulative incidence of T1D by early life animal exposure are shown in Figure 3. There 
is not a statistically significant difference between the survival curves for T1D by early 
life animal exposure (p=0.89). 
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Table 4: Descriptive Statistics of the Study Population for the Analysis of Early Life 
Animal Exposures and Risk of IA and T1D 
Variable All  
N=7432 
N (%) 
Exposed to 
Animals in 
Early Life 
N=3987  
N (%)  
Not Exposed 
to Animals in 
Early Life 
N=3445 
N (%) 
P-value 
Sex 
Female 
Male 
 
3646 (49.06) 
3786 (50.94) 
 
1970 (49.41) 
2017 (50.59) 
 
1676 (48.65) 
1769 (51.35) 
 
0.5132 
Age at Last Visit, years 
(mean, SD) 
 
4.23 (1.83) 
 
4.19 (1.81) 
 
4.28 (1.86) 
 
0.0422 
HLA Allele 
DQ2/2 
DQ8/2 
DQ8/8 
DQ8/4 
Other 
 
1541 (20.73) 
2894 (38.94) 
1476 (19.86) 
1283 (17.26) 
238 (3.2) 
 
844 (21.17) 
1631 (40.91) 
766 (19.21) 
613 (15.37) 
133 (3.34) 
 
697 (20.23) 
1263 (36.66) 
710 (20.61) 
670 (19.45) 
105 (3.05) 
 
<0.0001 
First Degree Relative with 
T1D 
Yes 
No 
 
 
816 (10.98) 
6616 (89.02) 
 
 
449 (11.26) 
3538 (88.74) 
 
 
367 (10.65) 
3078 (89.35) 
 
 
0.4028 
Country of Residence 
United States 
Finland 
Germany 
Sweden 
 
3057 (41.13) 
1617 (21.76) 
497 (6.69) 
2261 (30.42) 
 
2091 (52.45) 
584 (14.65) 
252 (6.32) 
1060 (26.59) 
 
966 (28.04) 
1033 (29.99) 
245 (7.11) 
1201 (34.86) 
 
<0.0001 
Residence Type 
Rural Area 
Small City/Village 
Suburb 
Big City 
Missing 
 
1064 (14.35) 
2378 (32.06) 
2859 (38.55) 
1116 (15.05) 
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785 (19.74) 
1127 (28.34) 
1566 (39.38) 
499 (12.55) 
 
279 (8.11) 
1251 (36.37) 
1293 (37.59) 
617 (17.94) 
 
<0.0001 
Crowding Space   
(Residence Density) 
>1 (Crowded) 
≤ 1 (Not Crowded) 
Missing 
 
 
727 (9.85) 
6654 (90.15) 
51 
 
 
344 (8.68) 
3617 (91.32) 
 
 
383 (11.20) 
3037 (88.80) 
 
 
0.0003 
Mother’s Education Level 
Basic Primary Education 
Graduated Trade School 
Graduated College 
Missing 
 
1299 (17.74) 
1853 (25.31) 
4170 (56.95) 
110 
 
737 (18.77) 
1070 (27.25) 
2120 (53.99) 
 
562 (16.55) 
783 (23.06) 
2050 (60.38) 
 
<0.0001 
Mother Smoked During 
Pregnancy 
Yes 
No 
Missing 
 
 
895 (12.15) 
6469 (87.85) 
68 
 
 
529 (13.38) 
3424 (86.62) 
 
 
366 (10.73) 
3045 (89.27) 
 
 
0.0005 
Mother Drank Alcohol 
During Pregnancy 
Yes 
No 
Missing 
 
 
2546 (34.56) 
4820 (65.44) 
66 
 
 
1426 (36.08) 
2526 (63.92) 
 
 
1120 (32.81) 
2294 (67.19) 
 
 
0.0032 
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Mother Experienced a 
Condition or Illness During 
Pregnancy 
Yes 
No 
 
 
 
6767 (91.05) 
665 (8.95) 
 
 
 
3634 (91.15) 
353 (8.85) 
 
 
 
3133 (90.94) 
312 (9.06) 
 
 
 
0.7600 
Mother’s Age at Birth of 
Participant, years  
mean (SD) 
 
 
31.13 (5.16) 
 
 
31.09 (5.28) 
 
 
31.18 (5.03) 
 
 
0.4768 
Participant Birth Weight, 
grams  
mean (SD) 
Missing 
 
 
3503.6 (543.80) 
189 
 
 
3487.7 (543.4) 
 
 
 
3521.8 (543.7) 
 
 
0.0077 
Exclusive Breastfeeding 
Duration 
No exclusive breastfeeding 
<3 months 
≥ 3 months 
 
 
2764 (37.19) 
2838 (38.19) 
1830 (24.62) 
 
 
1551 (38.90) 
1523 (38.20) 
913 (22.90) 
 
 
1213 (35.21) 
1315 (38.17) 
917 (26.62) 
 
 
0.0002 
Early Life Formula 
Introduction Age  
Not introduced 
Introduced at <3 months 
Introduced at 3-<7.5 months 
Introduced at 7.5-<9 months 
Missing 
 
 
1094 (15.11) 
5196 (71.78) 
827 (11.42) 
122 (1.69) 
193 
 
 
554 (14.36) 
2821 (73.12) 
419 (10.86) 
64 (1.66) 
 
 
540 (15.97) 
2375 (70.25) 
408 (12.07) 
58 (1.72) 
 
 
0.0574 
Early Life Cow Milk 
Introduction Age 
Not introduced 
Introduced <3 months 
Introduced 3-<7.5 months 
Introduced 7.5-<9 months 
Missing 
 
 
25 (0.36) 
5058 (73.01) 
1618 (23.35) 
227 (3.28) 
504 
 
 
13 (0.35) 
2769 (75.14) 
786 (21.33) 
117 (3.18) 
 
 
12 (0.37) 
2289 (70.58) 
832 (25.66) 
110 (3.39) 
 
 
0.0003 
Early Life Vaccination 
Yes 
No 
 
7077 (95.22) 
355 (4.78) 
 
3783 (94.88) 
204 (5.12) 
 
3294 (95.62) 
151 (4.38) 
 
0.1393 
Early Life Social Group  
Yes 
No 
 
4800 (64.59) 
2632 (35.41) 
 
2624 (65.81) 
1363 (34.19) 
 
2176 (63.16) 
1269 (36.84) 
 
0.0172 
 
Table 5: Cross-tabulation of Early Life Animal Exposure and Persistent, Confirmed IA 
 IA 
N (%) 
No IA 
N (%) 
Total 
N (%) 
Early Life Animal 
Exposure 221 (52.99) 3766 (53.68) 3987 (53.65) 
No Early Life Animal 
Exposure 196 (47.00) 3249 (46.32) 3445 (46.35) 
Total 417 (5.61) 7015 (94.39) 7432 (100) 
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Figure 2: Kaplan-Meier Survival Curve, Cumulative Incidence of Persistent, Confirmed 
IA by Early Life Animal Exposure, Log Rank P=0.92 
 
  
Figure 3: Kaplan-Meier Survival Curve, Cumulative Incidence of T1D by Early Life 
Animal Exposure, Log Rank P=0.89 
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Table 6: Cross-tabulation of Early Life Exposure to Animals and T1D 
 T1D 
N (%) 
No T1D 
N (%) 
Total  
N (%) 
Early Life Animal 
Exposure 59 (52.21) 3928 (53.67) 3987 (53.65) 
No Early Life Animal 
Exposure 54 (47.79) 3391 (46.33) 3445 (46.35) 
Total  113 (1.52) 7319 (98.48) 7432 (100) 
 
Logistic Regression 
 All variables of interest (listed in Table 4) that were thought to potentially impact 
the probability that one would be exposed to an animal/pet were included in the initial 
logistic regression model and then assessed by stepwise logistic regression. This 
resulted in all variables of interest being included in the initial model with the exception of 
HLA allele type and participant age at last visit, which would be accounted for in the 
survival analysis instead. Stepwise logistic regression, based on a significance level of 
0.1 for entry and to stay in the model, resulted in a final model including eight variables: 
country of residence, residence type, smoking by the mother during pregnancy, 
crowding space (residence density), early life vaccination, maternal education, early life 
social group exposure, and drinking alcohol by the mother during pregnancy.  
The final logistic regression model was used to create the propensity score for 
each participant, representing the probability of early life animal exposure based on the 
eight variables included in the final model (country of residence, residence type, smoking 
by the mother during pregnancy, crowding space, early life vaccination, maternal 
education, early life social group exposure, and drinking alcohol by the mother during 
pregnancy) as predictors. Only those participants with complete data (N=6,532) for the 
variables assessed in the stepwise logistic regression were included in the logistic 
regression analysis. The odds ratios (OR) and corresponding 95% confidence intervals 
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(CI) as well as the p-values associated with each of the variables included in the final 
model are listed in Table 7. 
 
Table 7: Final Logistic Regression Model for Early Life Animal Exposure Propensity 
Score Calculation, Stepwise Logistic Regression, Significance Level of 0.1 for Model 
Entry and to Stay in Model, N=6,532 
Variable OR (95% CI) P-value 
Country of Residence (Ref = United States) 
Finland  
Germany  
Sweden  
 
0.20 (0.17-0.23) 
0.39 (0.31-0.48) 
0.31 (0.27-0.36) 
 
<0.0001 
Residence Type (Ref = Big City) 
Rural 
Small city/village 
Suburb 
 
5.87 (4.75-7.25) 
1.81 (1.52-2.14) 
1.50 (1.28-1.76) 
 
<0.0001 
Smoking During Pregnancy (Ref= None) 1.35 (1.14-1.59) <0.0001 
Crowding Space (Ref = Crowding Score ≤1)  0.74 (0.61-0.89) 0.0010 
Early Life Vaccination (Ref = None) 1.50 (1.15-1.94) 0.0036 
Maternal Education (Ref = Primary Education) 
Graduated Trade School/Some College 
Graduated College 
 
0.96 (0.81-1.13) 
0.78 (0.67-0.91) 
 
0.0027 
Early Life Social Group Exposure (Ref = None) 1.17 (1.04-1.31) 0.0045 
Drinking During Pregnancy (Ref = None) 1.11 (0.99-1.25) 0.0601 
 
 These results indicate that the odds of being exposed to animals early in life 
among participants in Finland, Germany, or Sweden are lower than the odds of being 
exposed to animals early in life among participants in the U.S. The odds of being 
exposed to animals early in life among those living in a rural environment are 5.9 times 
(OR: 5.87, 95% CI: 4.75-7.25) the odds of being exposed to animals early in life among 
those living in a big city. Also in regard to environment, those who live in a crowded 
environment have lower odds (OR: 0.74, 95% CI: 0.61-0.89) of early life animal 
exposure than those who do not live in a crowded environment. Those participants 
whose mothers smoked during pregnancy have higher odds (OR: 1.35, 95% CI: 1.14-
1.59) of early life animal exposure than those whose mothers did not and those whose 
mothers drank alcohol during pregnancy have higher odds (OR: 1.11, 95% CI: 0.99-
1.25) of early life animal exposure than those whose mothers did not. Additionally, those 
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who received early life vaccinations have higher odds (OR: 1.50, 95% CI: 1.15-1.94) of 
early life animal exposure than those who did not and those who had early life social 
group experiences have higher odds (OR: 1.17, 95% CI: 1.04-1.31) of early life animal 
exposure than those who did not. 
 
Propensity Score Application 1 
 The association between early life animal exposure and each outcome was first 
explored by examining the study population (N=7,432) as a whole. Propensity scores 
could not be calculated for 241 participants who were missing at least one of the eight 
variables included in the final logistic regression model used to calculate the propensity 
scores. The Cox proportional hazards models utilized to assess the association between 
early life animal exposure and each outcome were run on the 7,191 participants for 
whom propensity scores could be calculated. 
 
Outcome: Persistent, Confirmed IA 
Before controlling for any other variables, the hazard ratio (HR) for the risk of 
persistent, confirmed IA among those with early life animal exposure compared to those 
without early life animal exposure was 1.02 with a 95% CI of 0.84-1.24. Since the 95% 
CI for this basic unadjusted association includes 1, the finding is not statistically 
significant. Therefore, no difference in risk of persistent, confirmed IA was found 
between those participants with early life animal exposure and those without early life 
animal exposure. 
The propensity score variable was added to the original unadjusted model in 
order to control for the variables that were predictive of early life animal exposure and 
determine if the HR was altered by the adjusted model (Table 8, Adjusted Model 1). 
When adjusted for early life animal exposure propensity, the resulting HR was 1.11 
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(0.90-1.37). This measure of association indicates that there is no significant difference 
in IA risk between those with early life animal exposure and those without early life 
animal exposure.  
Adjusting for HLA type in addition to propensity score (Table 8, Adjusted Model 
2) had little additional impact on the HR (HR 1.09, 95% CI: 0.89-1.35). This finding was 
not statistically significant and indicates no significant difference in risk between the 
exposed and unexposed. Ultimately, no statistically significant associations were 
identified between early life animal exposure and persistent, confirmed IA by the models 
run on the entire study population. The findings of these models are summarized in 
Table 8.  
 
Table 8: HR & 95% CI for Early Life Animal Exposure and Persistent, Confirmed IA by 
Cox PH Models Fit to the Entire Study Population 
 Risk of IA for Participants with Early Life Animal Exposure1 
Variable Unadjusted Model 
N=7191 
HR (95% CI) 
Adjusted Model 1 
N=7191 
HR (95% CI) 
Adjusted Model 2 
N=7191 
HR (95% CI) 
Early Life 
Animal 
Exposure 
1.02 (0.84-1.24) 1.11 (0.90-1.37) 1.09 (0.89-1.35) 
1 The unadjusted model includes early life animal exposure only (reference group unexposed). 
Adjusted model 1 is adjusted for early life animal exposure propensity score. Adjusted model 2 is 
adjusted for propensity score and HLA (reference group DQ8/8).  
 
 
Outcome: T1D 
Before controlling for any other variables, the HR for the risk of T1D among those 
with early life animal exposure compared to those without early life animal exposure was 
0.98 with a 95% CI of 0.67-1.42. Since the 95% CI for this basic unadjusted association 
includes 1, the finding is not statistically significant and indicates no difference in risk 
between the exposed and unexposed groups. As was done for analysis of IA risk, 
propensity score was added to the analysis for T1D risk in order to control for the 
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variables that were predictive of early life animal exposure and determine if the HR was 
altered by the adjusted model. When adjusted for early life animal exposure propensity 
(Table 9, Adjusted Model 1), the resulting HR for T1D risk was 1.04 (0.69-1.54). This 
measure of association indicates that there is no significant difference in T1D risk 
between those with early life animal exposure and those without early life animal 
exposure.  
Adjusting for HLA type in addition to propensity score (Table 9, Adjusted Model 
2) also resulted in no significant difference in the risk of T1D between the exposed and 
unexposed groups (HR: 1.01, 95% CI: 0.67-1.50). In summary, none of the measured 
associations between early life animal exposure and T1D, examined by running models 
on the entire study population, indicated a statistically significant difference in risk 
between the exposed and unexposed. The findings of these models are summarized in 
Table 9.  
 
Table 9: HR & 95% CI for Early Life Animal Exposure and T1D by Cox PH Models Fit to 
the Entire Study Population 
 Risk of T1D for Participants with Early Life Animal Exposure1 
Variable Unadjusted Model 
N=7191 
HR (95% CI) 
Adjusted Model 1 
N=7191 
HR (95% CI) 
Adjusted Model 2 
N=7191 
HR (95% CI) 
Early Life 
Animal 
Exposure 
0.98 (0.67-1.42) 1.04 (0.69-1.54) 1.01 (0.67-1.50) 
1 The unadjusted model includes early life animal exposure only (reference group unexposed). 
Adjusted model 1 is adjusted for early life animal exposure propensity score. Adjusted model 2 is 
adjusted for propensity score and HLA (reference group DQ8/8).  
 
 
Propensity Score Application 2 
Quintiles Overview 
 The total number of participants in each propensity score quintile ranges from 
1396 to 1481 with each quintile representing 19% to 20% of the total study population. 
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The propensity score range of each quintile, as well as the distribution of exposure and 
outcomes across quintiles, is detailed in Table 10. Quintile 1 includes those participants 
with the lowest propensity scores indicating that they have a low probability of early life 
animal exposure. Conversely, quintile 5 includes those participants with the highest 
propensity scores indicating that these participants have a high probability of early life 
animal exposure. As expected, quintile 1 (the quintile with the lowest propensity scores) 
had the lowest percent of exposed participants. The percent exposed then increased 
with each quintile through quintile 5 (the quintile with the highest propensity scores) 
which had the highest percent of exposed participants. This indicates that the propensity 
scores were appropriately predicting early life animal exposure in the study population. 
Propensity scores could not be calculated for 241 participants who were missing at least 
one of the eight variables included in the final logistic regression model used to calculate 
the propensity scores. As shown in Table 10, the group of participants for whom 
propensity score could not be calculated had a high proportion of early life animal 
exposure (54%) and a low proportion of IA (4%) and T1D (<1%) which may attenuate 
the HRs calculated for these outcomes. The characteristics of study participants by 
propensity score quintile are further detailed in Table 11. 
The Kaplan-Meier survival curves for persistent, confirmed IA by early life animal 
exposure propensity quintile are shown in Figure 4 and the Kaplan-Meier curves for T1D 
by early life animal exposure propensity quintile are shown in Figure 5. There is not a 
statistically significant difference between the survival curves for IA by early life animal 
exposure propensity quintile (p=0.57) or between the survival curves for T1D by early life 
animal exposure propensity quintile (p=0.76). 
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Table 10: Early Life Animal Exposure Propensity Score Quintiles: Range, Total, Number 
Exposed, Number with Persistent Confirmed IA, and Number with T1D 
Propensity 
Score Quintile 
Propensity Score 
Range 
Total  
N (%) 
Exposed  
N (%) 
IA  
Outcome  
N (%) 
T1D 
Outcome  
N (%) 
1  0.140-<0.355 1444 (19.43) 409 (28.32) 99 (6.86) 29 (2.01) 
2  0.355-<0.470 1431 (19.25) 554 (38.71) 83 (5.80) 23 (1.61) 
3 0.470-<0.619 1439 (19.36) 857 (59.56) 80 (5.56) 22 (1.53) 
4  0.619-<0.689 1481 (19.93) 1017 (68.67) 77 (5.20) 22 (1.49) 
5  0.689-<0.938 1396 (18.78) 1019 (72.99) 68 (4.87) 15 (1.07) 
Missing  241 (3.24) 131 (54.36) 10 (4.15) 2 (0.83) 
 
  
Figure 4: Survival Curves for Persistent, Confirmed IA by Early Life Animal Exposure 
Propensity Score Quintile (Survival by Time to Event), Log Rank P=0.57 
 
Figure 5: Survival Curve for T1D by Early Life Animal Exposure Propensity Score 
Quintile (Survival by Time to Event), Log Rank P=0.76 
Kaplan-Meier Survival Curve for Persistent, Confirmed Autoantibodies by Early Life Animal Exposure Quintile
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Kaplan-Meier Survival Curve for T1D by Early Life Animal Exposure Quintile
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Table 11: Descriptive Statistics of the Study Population by Early Life Animal Exposure Propensity Quintile 
Variable Early Life Animal Exposure Propensity Quintiles 
(Lowest Propensity, Q1, to Highest Propensity, Q5, for Animal Exposure)  
Quintile 1  
N=1444 
N (%) 
Quintile 2 
N=1431 
N (%) 
Quintile 3 
N=1439 
N (%) 
Quintile 4 
N=1481 
N (%)  
Quintile 5 
N=1396 
N (%) 
Early Life Animal Exposure  
Yes 
No 
 
409 (23.32) 
1035 (71.68) 
 
554 (38.71) 
877 (61.29) 
 
857 (59.56) 
582 (40.44) 
 
1017 (68.67) 
464 (31.33) 
 
1019 (72.99) 
377 (27.01) 
Sex 
Female 
Male 
 
723 (50.07) 
721 (49.93) 
 
692 (48.36) 
739 (51.64) 
 
708 (49.20) 
731 (50.80) 
 
727 (49.09) 
754 (50.91) 
 
671 (48.07) 
725 (51.93) 
Age at Last Visit, years 
(mean, SD) 
 
4.50 (1.84) 
 
4.45 (1.93) 
 
4.14 (1.87) 
 
4.12 (1.69) 
 
3.95 (1.75) 
HLA Allele 
2/2 
8/2 
8/8 
8/4 
Other 
 
224 (15.51) 
510 (35.32) 
260 (18.01) 
399 (27.63) 
51 (3.53) 
 
302 (21.10) 
564 (39.41) 
307 (21.45) 
221 (15.44) 
37 (2.59) 
 
317 (22.03) 
543 (37.73) 
305 (21.2) 
210 (14.59) 
64 (4.45) 
 
330 (22.28) 
620 (41.86) 
275 (18.57) 
218 (14.72) 
38 (2.57) 
 
319 (22.85) 
565 (40.47) 
284 (20.34) 
185 (13.25) 
43 (3.08) 
First Degree Relative with T1D 
Yes 
No 
 
134 (9.28) 
1310 (90.72) 
 
136 (9.50) 
1295 (90.50) 
 
179 (12.44) 
1260 (87.56) 
 
174 (11.75) 
1307 (88.25) 
 
170 (12.18) 
1226 (87.82) 
Country of Residence 
United States 
Finland 
Germany 
Sweden 
 
0 (0) 
1055 (73.06) 
73 (5.06) 
316 (21.88) 
 
10 (0.70) 
192 (13.42) 
155 (10.83) 
1074 (75.05) 
 
586 (40.72) 
193 (13.41) 
181 (12.58) 
479 (33.29) 
 
1333 (90.01) 
85 (5.74) 
19 (1.28) 
44 (2.97) 
 
1007 (72.13) 
27 (1.93) 
67 (4.80) 
295 (21.13) 
Residence Type 
Rural Area 
Small City/Village 
Suburb 
Big City 
 
0 (0) 
489 (33.86) 
525 (36.36) 
430 (29.78) 
 
4 (0.28) 
808 (56.46) 
513 (35.85) 
106 (7.41) 
 
194 (13.48) 
597 (41.49) 
191 (13.27) 
457 (31.76) 
 
133 (8.98) 
102 (6.89) 
1172 (79.14) 
74 (5.00) 
 
702 (50.29) 
316 (22.64) 
369 (26.43) 
9 (0.64) 
Crowding Space  (Residence Density) 
>1 (Crowded) 
≤ 1 (Not Crowded) 
 
243 (16.83) 
1201 (83.17) 
 
112 (7.83) 
1319 (92.17) 
 
148 (10.28) 
1291 (89.72) 
 
100 (6.75) 
1381 (93.25) 
 
91 (6.52) 
1305 (93.48) 
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Mother’s Education Level 
Basic Primary Education 
Graduated Trade School 
Graduated College 
 
91 (6.30) 
239 (16.55) 
1114 (77.15) 
 
286 (19.99) 
328 (22.92) 
817 (57.09) 
 
413 (28.70) 
382 (26.55) 
644 (44.75) 
 
108 (7.29) 
253 (17.08) 
1120 (75.62) 
 
365 (26.15) 
611 (43.77) 
420 (30.09) 
Mother Smoked During Pregnancy 
Yes 
No 
 
73 (5.06) 
1371 (94.94) 
 
187 (13.07) 
1244 (86.93) 
 
213 (14.80) 
1226 (85.20) 
 
75 (5.06) 
1406 (94.94) 
 
310 (22.21) 
1086 (77.79) 
Mother Drank Alcohol During Pregnancy
Yes 
No 
 
438 (30.33) 
1006 (69.97) 
 
440 (30.75) 
991 (69.25) 
 
529 (36.76) 
910 (63.24) 
 
543 (36.66) 
938 (63.34) 
 
530 (37.97) 
866 (62.03) 
Mother Experienced a Condition or Illness 
During Pregnancy 
Yes 
No 
 
 
1324 (91.69) 
120 (8.31) 
 
 
1322 (92.38) 
109 (7.62) 
 
 
1304 (90.62) 
135 (9.38) 
 
 
1357 (91.63) 
124 (8.37) 
 
 
1297 (92.91) 
99 (7.09) 
Mother’s Age at Birth of Participant, years 
mean (SD) 
 
31.24 (4.67) 
 
31.35 (4.82) 
 
31.36 (5.15) 
 
31.78 (5.14) 
 
30.01 (5.70) 
Participant Birth Weight, grams  
mean (SD) 
 
3554.25 (541.01) 
 
3550.55 (532.34) 
 
3510.41 (547.57) 
 
3422.53 (524.29) 
 
3472.89 (556.80) 
Exclusive Breastfeeding Duration 
No exclusive breastfeeding 
<3 months 
≥ 3 months 
 
442 (30.61) 
571 (39.54) 
431 (29.85) 
 
425 (29.70) 
573 (40.04) 
433 (30.26) 
 
501 (34.82) 
588 (40.86) 
350 (24.32) 
 
723 (48.82) 
449 (30.32) 
309 (20.86) 
 
589 (42.19) 
540 (38.68) 
267 (19.13) 
Early Life Formula Introduction Age  
Not introduced 
Introduced at <3 months 
Introduced at 3-<7.5 months 
Introduced at 7.5-<9 months 
 
232 (16.08) 
970 (67.22) 
204 (14.14) 
37 (2.56) 
 
271 (19.02) 
974 (68.35) 
165 (11.58) 
15 (1.05) 
 
201 (14.36) 
997 (71.21) 
177 (12.64) 
25 (1.79) 
 
187 (13.24) 
1069 (75.71) 
128 (9.07) 
28 (1.98) 
 
181 (13.67) 
998 (75.38) 
132 (9.97) 
13 (0.98) 
Early Life Cow Milk Introduction Age 
Not introduced 
Introduced <3 months 
Introduced 3-<7.5 months 
Introduced 7.5-<9 months 
 
7 (0.52) 
912 (67.16) 
387 (28.50) 
52 (3.83) 
 
3 (0.21) 
968 (68.75) 
418 (29.69) 
19 (1.35) 
 
6 (0.45) 
988 (74.29) 
285 (21.43) 
51 (3.83) 
 
9 (0.67) 
1028 (77.06) 
229 (17.17) 
68 (5.10) 
 
0 (0) 
978 (76.89) 
264 (20.75) 
30 (2.36) 
Early Life Vaccination 
Yes 
No 
 
1407 (97.44) 
37 (2.56) 
 
1392 (97.27) 
39 (2.73) 
 
1299 (90.27) 
140 (9.73) 
 
1420 (95.88) 
61 (4.12) 
 
1346 (96.42) 
50 (3.58) 
Early Life Social Group  
Yes 
No 
 
789 (54.64) 
655 (45.36) 
 
929 (64.92) 
502 (35.08) 
 
1000 (69.49) 
439 (30.51) 
 
975 (68.83) 
506 (34.17) 
 
968 (69.34) 
428 (30.66) 
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Notably, the quintiles are largely characterized by country of residence (Table 
11). For example, 73% of quintile 1 is comprised of Finland participants and there are no 
U.S. participants in this quintile. Quintile 2, on the other hand, includes mostly 
participants from Sweden (75%). The distribution of quintile 3 is less extreme with 33% 
of participants from Sweden, 13% from Germany, 13% from Finland, and 41% from the 
U.S.; however, quintile 4 is almost entirely made up of U.S. participants (90%). Quintile 5 
is then basically the opposite of quintile 1 with 72% U.S. participants and very few 
participants from Finland (2%). The DQ8/4 allele also has higher prevalence in quintile 1 
(the quintile comprised mostly of Finland participants) than the other quintiles. The 
quintiles are also largely characterized by residence type, specifically rural residence. No 
participants in quintile 1 (the group with the lowest predicted probably of animal 
exposure) lived in rural areas. Conversely, 50% of participants in quintile 5 (the group 
with the highest predicted probably of animal exposure) lived in rural areas.  
 
Outcome: Persistent, Confirmed IA 
No statistically significant associations between early life animal exposure and 
persistent, confirmed IA were found for quintiles 2, 3, 4, or 5. This was true even after 
directly adjusting for HLA type. Quintile 1, however, did produce a statistically significant 
finding. The results indicate that those participants in quintile 1 who were exposed to 
animals in early life have a 54% higher risk of developing persistent, confirmed IA than 
those participants who were not exposed to animals in early life (HR: 1.54, 95% CI: 1.02-
2.31). Adjusting for HLA type had little impact on the resulting HR (HR: 1.53, 95% CI: 
1.02-2.30). These findings are detailed in Table 12. Despite the statistically significant 
association identified in the quintile 1 population, a statistically significant difference in 
risk of persistent, confirmed IA across the quintiles was not found (p=0.57), indicating no 
overall association between early life animal exposure and persistent, confirmed IA . 
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Outcome: T1D 
 No statistically significant associations between early life animal exposure and 
T1D were found for any of the propensity score quintiles (Table 13). This was true for all 
quintiles even after adjusting for HLA type. Additionally, a statistically significant 
difference in risk of T1D across the quintiles was not found (p=0.76).  
 
Table 12: HR & 95% CI for Cox PH Models for Outcome Persistent, Confirmed IA run 
within Early Life Animal Exposure Propensity Score Quintiles 
 Risk of IA by Propensity Score Quintile1 
Propensity 
Score 
Quintile 
Exposure Group 
 
Unadjusted Model  
HR (95% CI) 
Adjusted Model 1  
HR (95% CI) 
1 Exposed 1.54 (1.02-2.31) 1.53 (1.02-2.30) Unexposed 1 (Ref) 1 (Ref) 
2 Exposed 0.79 (0.50-1.24) 0.76 (0.48-1.21) Unexposed 1 (Ref) 1 (Ref) 
3 Exposed 0.86 (0.56-1.34) 0.86 (0.55-1.34) Unexposed 1 (Ref) 1 (Ref) 
4 Exposed 1.35 (0.80-2.26) 1.30 (0.78-2.19) Unexposed 1 (Ref) 1 (Ref) 
5 Exposed 1.12 (0.64-1.97) 1.10 (0.63-1.94) Unexposed 1 (Ref) 1 (Ref) 
1 The unadjusted model includes early life animal exposure only (reference group unexposed). 
Adjusted model 1 is adjusted for HLA (reference group DQ8/8).  
 
Table 13: HR & 95% CI for Cox PH Models for Outcome T1D run within Early Life 
Animal Exposure Propensity Score Quintiles 
 
Risk of T1D by Propensity Score 
Quintile1 
Propensity 
Score 
Quintile 
Exposure Group Unadjusted Model  
HR (95% CI) 
Adjusted Model 1  
HR (95% CI) 
1 Exposed 1.52 (0.72-3.23) 1.46 (0.69-3.10) Unexposed 1 (Ref) 1 (Ref) 
2 Exposed 0.35 (0.12-1.04) 0.33 (0.11-0.97) Unexposed 1 (Ref) 1 (Ref) 
3 Exposed 0.97 (0.42-2.27) 0.92 (0.39-2.15) Unexposed 1 (Ref) 1 (Ref) 
4 Exposed 1.48 (0.55-4.02) 1.45 (0.53-3.92) Unexposed 1 (Ref) 1 (Ref) 
5 Exposed 2.10 (0.47-9.31) 2.07 (0.46-9.20) Unexposed 1 (Ref) 1 (Ref) 
1 The unadjusted model includes early life animal exposure only (reference group unexposed). 
Adjusted model 1 is adjusted for HLA (reference group DQ8/8).  
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Propensity Score Application 3 
 Exposed and unexposed participants with propensity scores within 0.1 of one 
another were matched as pairs. This resulted in a total of 2,510 matched pairs (5,020 
participants). The characteristics of the matched study population for the variables used 
to calculate propensity score are detailed in Table 14.  
 
Table 14: Descriptive Statistics of the Matched Study Population for Variables Used in 
the Calculation of Propensity Score, N=5,020 
Variable All  
N=5,020 
N (%) 
Exposed to 
Animals in 
Early Life 
N=2,510 
N (%)  
Not Exposed 
to Animals in 
Early Life 
N=2,510 
N (%) 
P-value 
Country of Residence 
United States 
Finland 
Germany 
Sweden 
 
1886 (37.57) 
1030 (20.52) 
402 (8.01) 
1702 (33.90) 
 
956 (38.09) 
511 (20.36) 
208 (8.29) 
835 (33.27) 
 
930 (37.05) 
519 (20.68) 
194 (7.73) 
867 (34.54) 
 
<0.0001 
Residence Type 
Rural Area 
Small City/Village 
Suburb 
Big City 
 
574 (11.43) 
1850 (36.85) 
1820 (36.25) 
776 (15.46) 
 
302 (12.03) 
940 (37.45) 
883 (35.18) 
385 (15.34) 
 
272 (10.84) 
910 (36.25) 
937 (37.33) 
391 (15.58) 
 
<0.0001 
Crowding Space 
(Residence Density)   
>1 (Crowded) 
≤ 1 (Not Crowded) 
 
 
500 (9.96) 
4520 (90.04) 
 
 
246 (9.80) 
2264 (90.20) 
 
 
254 (10.12) 
2256 (89.88) 
 
 
0.0829 
Mother’s Education Level 
Basic Primary Education 
Graduated Trade School 
Graduated College 
 
1008 (20.08) 
1301 (25.92) 
2711 (54.00) 
 
529 (21.08) 
655 (26.10) 
1326 (52.83) 
 
479 (19.08) 
646 (25.74) 
1385 (55.18) 
 
<0.0001 
Mother Smoked During 
Pregnancy 
Yes 
No 
 
 
601 (11.97) 
4419 (88.03) 
 
 
310 (12.35) 
2200 (87.65) 
 
 
291 (11.59) 
2219 (88.41) 
 
 
0.3209 
Mother Drank Alcohol 
During Pregnancy 
Yes 
No 
 
 
1670 (33.27) 
3350 (66.73) 
 
 
824 (32.83) 
1686 (67.17) 
 
 
846 (33.71) 
1664 (66.29) 
 
 
0.3287 
Early Life Vaccination 
Yes 
No 
 
4781 (95.24) 
239 (4.76) 
 
2390 (95.22) 
120 (4.78) 
 
2391 (95.26) 
119 (4.74) 
 
0.4629 
Early Life Social Group  
Yes 
No 
 
3218 (64.10) 
1802 (35.90) 
 
1592 (63.43) 
918 (36.57) 
 
1626 (64.78) 
884 (35.22) 
 
0.2966 
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Outcome: Persistent, Confirmed IA 
No statistically significant associations between early life animal exposure and 
persistent, confirmed IA were found when stratifying by matched pair. This was true 
even when directly adjusting for HLA type. These findings are detailed in Table 15.  
 
Outcome: T1D 
No statistically significant associations between early life animal exposure and 
TID were found when stratifying by matched pair. This was true even when directly 
adjusting for HLA type. These findings are detailed in Table 16.  
 
Table 15: HR & 95% CI for Persistent, Confirmed IA, Cox PH Models on Matched Study 
Population, N=5,020 
 Risk of IA for Participants with Early Life Animal Exposure1 
Variable Unadjusted Model 
HR (95% CI) 
Adjusted Model 1  
HR (95% CI) 
Early Life Animal 
Exposure 1.02 (0.78-1.32) 0.99 (0.75-1.29) 
1 The unadjusted model includes early life animal exposure only (reference group unexposed). 
Adjusted model 1 is adjusted for HLA (reference group DQ8/8).  
 
 
Table 16: HR & 95% CI for T1D, Cox PH Models on Matched Study Population, N=5,020 
 Risk of T1D for Participants with Early Life Animal Exposure1 
Variable Unadjusted Model 
HR (95% CI) 
Adjusted Model 1  
HR (95% CI) 
Early Life Animal 
Exposure 0.77 (0.45-1.32) 0.77 (0.44-1.36) 
1 The unadjusted model includes early life animal exposure only (reference group unexposed). 
Adjusted model 1 is adjusted for HLA (reference group DQ8/8).  
 
Additional Analyses 
Testing the Proportional Hazards Assumptions 
The assumptions of the Cox proportional hazards model were explored and 
confirmed. Details of this analysis are provided in Appendix 3. 
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Testing for Interactions  
The unadjusted Cox proportional hazards models for each outcome (persistent, 
confirmed IA and T1D) were run within categories of variables of interest to determine if 
there were interactions between the early life animal exposure variable and other 
covariates. Variables of interest are those variables included in the final logistic 
regression model, as well as HLA which was included in adjusted models. The HR and 
corresponding 95% CI for each outcome by variable category are summarized in Table 
17. No statistically significant interactions were identified. 
 
Table 17: HR & 95% CI for Unadjusted Cox PH Models run within Variable Categories to 
Check for Potential Interactions 
Variable Category IA Outcome 
HR (95% CI) 
 T1D Outcome 
HR (95% CI) 
Country of Residence US 0.992 (0.687-1.432)  1.037 (0.498-2.162) 
Finland 1.393 (0.955-2.030)  1.311 (0.670-2.562) 
Germany 1.032 (0.497-2.141)  1.136 (0.425-3.039) 
Sweden 0.931 (0.670-1.294)  0.763 (0.354-1.644) 
Residence Type Rural 1.363 (0.756-2.456)  3.243 (0.753-13.973) 
Small City/Village 0.775 (0.551-1.088)  0.797 (0.427-1.485) 
Suburb 1.058 (0.772-1.452)  0.780 (0.412-1.476) 
Big City 1.005 (0.594-1.703)  0.939 (0.326-2.707) 
Maternal Education High 1.075 (0.839-1.377)  0.964 (0.586-1.586) 
Low 0.925 (0.679-1.260)  0.998 (0.571-1.745) 
Crowding - Binary 
 
Score >1 1.954 (0.978-3.902)  2.070 (0.606-7.075) 
Score ≤ 1 0.925 (0.757-1.132)  0.879 (0.595-1.299) 
Crowding - Quintiles Quintile 1 1.169 (0.738-1.852) 0.778 (0.365-1.662) 
Quintile 2 0.983 (0.635-1.524) 0.944 (0.372-2.395) 
Quintile 3 0.877 (0.566-1.360) 0.863 (0.378-1.969) 
Quintile 4 0.866 (0.515-1.456) 0.637 (0.227-1.791) 
Quintile 5 1.095 (0.75-1.600) 1.518 (0.722-3.190) 
Smoking During 
Pregnancy 
Yes 1.221 (0.615-2.423)  1.419 (0.260-7.749) 
No 0.992 (0.811-1.214)  0.965 (0.661-1.411) 
Early Life Vaccination Yes 1.00 (0.823-1.215)  0.978 (0.669-1.429) 
No 0.662 (0.177-2.478)  0.848 (0.170-4.236) 
Early Life Social 
Group 
Yes 1.020 (0.804-1.294)  1.189 (0.732-1.932) 
No 0.939 (0.676-1.303)  0.737 (0.411-1.320) 
Drinking During 
Pregnancy 
Yes 0.856 (0.614-1.194)  0.863 (0.461-1.618) 
No 1.077 (0.850-1.364)  1.034 (0.655-1.631) 
HLA 2/2 0.779 (0.455-1.335)  0.680 (0.208-2.230) 
8/2 1.021 (0.779-1.339)  0.851 (0.515-1.409) 
8/8 1.045 (0.656-1.665)  0.990 (0.347-2.825) 
8/4 1.037 (0.635-1.694)  1.865 (0.677-5.133) 
FDR 0.714 (0.275-1.850)  0.971 (0.296-3.181) 
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Discussion 
 The purpose of this study was to assess the association between early life 
animal exposure and development of T1D, considering two separate endpoints: 
persistent, confirmed IA and T1D diagnosis. The relationship between early life animal 
exposure and each of these endpoints was assessed utilizing three different propensity 
score analysis techniques: model adjustment for propensity score, stratification on 
propensity score, and propensity score pair matching. Overall, this study does not 
support an association between early life animal exposure and persistent, confirmed IA 
or between early life animal exposure and T1D diagnosis. The findings of this study 
indicate no significant difference in T1D risk or IA risk among those with early life animal 
exposure compared to those without early life animal exposure. These findings were 
consistent even when directly adjusted for HLA type. 
This study is one of only a few studies that have previously been conducted on 
animal exposure and T1D in children and the first we are aware of that examines early 
life animal exposure and persistent, confirmed IA. The results of this study are consistent 
with the results reported by Radon et al. (19). Radon et al. specifically focused on 
regular (at least once per week) contact to stables and T1D diagnosis and examined the 
association for those exposed in the first year of life and those exposed in the second to 
sixth year of life. Radon et al. did not find a statistically significant association, defined as 
p<0.05, between stables (farm animals) exposure and T1D, regardless of age at 
exposure. Radon et al. also did not find a statistically significant association between 
pets and T1D. The study by Radon et al. differs from the study currently being reported 
in that they examined farm animal exposure specifically, included only participants from 
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6 to 16 years of age who lived in rural areas of Germany with less than 100,000 
residents, and utilized only T1D diagnosis as an endpoint. Additionally, the Radon et al. 
study is a case-control study including 242 cases and 224 controls. In comparison, the 
study currently being reported is a prospective cohort study including 7,432 participants 
enrolled in four different countries without limitation in scope to a particular residence 
type (e.g., rural) or particular animal type (e.g., farm animal) and with examination of 
both T1D diagnosis and persistent, confirmed IA as endpoints. 
  The results of this study differ from the results reported by Marshall et al. (17). 
Marshall et al. reported a statistically significant protective association between regular 
contact with pets/animals and T1D (p=0.045). Their finding was not reproduced in the 
study currently being reported. Marshall et al. performed a matched case-control study 
including 196 cases and 381 controls consisting of children under the age of 16 years 
living in the United Kingdom. It is not clear whether the data used by Marshall et al. to 
study the association between animal exposure and T1D was limited to exposure during 
a certain period of life, or even if it was limited to exposure prior to T1D diagnosis.  
Studying the association between early life animal exposure and development of 
T1D in a multinational cohort is an advance for the field of study since previous studies 
on animal exposure and T1D have only focused on effects within national populations. 
However, studying a population that includes individuals from several countries also 
produces challenges. In this study, country appears to be a major factor in animal 
exposure propensity. It is possible that attitudes toward pet ownership and animal 
contact may differ by country. Koivusilta and Ojanlatva conducted a study on pet 
ownership in the Finnish population and found that pet ownership is associated with poor 
perceived health among the population (26). This perception could result in pet 
avoidance by a parent due to the knowledge of their child being at genetically high risk 
for T1D to a greater extent in Finland than in other countries. Finland also differs from 
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the other studied countries in that it has the highest incidence of T1D worldwide (5). Of 
the countries participating in TEDDY, the country of next highest incidence is Sweden, 
followed by the U.S. and then Germany.  
The study questionnaires had to be translated to multiple languages in order to 
accommodate the multiple countries in the TEDDY study. It is possible that exposure 
misclassification could have occurred due to slight differences in these translations that 
affect a participant’s understanding of the questions on animal exposure and whether or 
not exposure is recorded accurately for how the question was intended. For example, 
one of the questions pertaining to animal exposure on the questionnaire is whether the 
TEDDY child lives on a farm with animals or if there are animals that live outside of the 
child’s house. It is possible, depending how this question translates, that individuals in 
some countries may report any animals they encounter that live outside of the child’s 
house (regardless of who owns the animal); whereas, individuals in other countries may 
only report animals living outside the home that they own. These differences in 
interpretation could result in exposure misclassification that may attenuate the HR and 
cause concern for the internal validity of the study.  
While exposure misclassification cannot be ruled out, outcome misclassification 
is unlikely. T1D diagnosis was defined by uniform criteria across sites and was 
documented in detail by each of the clinical centers. IA cases were limited to persistent, 
confirmed cases only for the purposes of this analysis. This means that an individual 
must test positive for IA at two separate consecutive study visits and that these findings 
were confirmed by a second laboratory. Considering only persistent, confirmed IA cases 
as opposed to all cases of positive IA results limits the likelihood of outcome 
misclassification for the IA endpoint. 
External validity is limited in this study due to selection bias in regard to a 
systematic difference in the characteristics of the individuals selected for the TEDDY 
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study compared to the individuals not selected for the TEDDY study. The TEDDY study 
is specifically designed to enroll participants who are genetically at high risk for T1D, 
which does not accurately represent the general population. A population aware of its 
high genetic risk for T1D may have different exposure patterns than a general population 
that is not at high risk for T1D or is unaware of its genetic susceptibility to T1D. 
Therefore, findings in this study population may not apply to a general population.  
 An additional disadvantage of the cohort study design is the length of follow-up 
needed to obtain a large enough population of those with the outcomes of interest for 
analysis. In the present study, there were 113 (2%) participants with T1D and 417 (6%) 
participants with persistent, confirmed IA. However, the mean study participant age is 
only 4.23 (1.83) years. Study follow-up is intended to continue until age 15 years or T1D 
diagnosis, depending on the event that occurs first for each participant. At this time, 
power is limited in the ability to detect differences in risk for T1D. Performing this 
analysis again in the future after longer follow-up has been completed may elucidate on 
how cumulative animal exposure affects risk of T1D. An additional disadvantage 
associated with the length of follow-up is the risk for loss to follow-up. To minimize the 
effect of loss to follow-up on study analyses, the TEDDY study group has studied 
predictors for loss to follow-up in the study population to target individuals at high risk for 
loss to follow-up (22). Identifying the individuals at high risk for loss to follow-up allows 
clinical centers to take extra care in maintaining contact with these individuals and 
encouraging continued participation throughout the course of the study. 
Despite the noted limitations, there are several important strengths of the present 
study. One strength of the study is the prospective cohort study design. This study 
design allows for temporality between the exposure and outcome to be established. In 
the TEDDY study, participants are enrolled prior to T1D diagnosis which allows for the 
collection of exposure data before diagnosis and ensures temporal sequence. In 
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comparison, the other studies on this topic are case-control studies for which temporality 
can be questionable since exposure data is collected after diagnosis. 
Another advantage of the cohort study design is that it allows for the study of 
multiple outcomes. In this case, both persistent, confirmed IA and T1D diagnosis were 
studied as outcomes. Furthermore, the prospective cohort study design minimizes recall 
bias, which is a major limitation of the other referenced case-control studies on animal 
exposures and T1D. Recall bias is a type of measurement bias that is characterized by a 
systemic difference in the way cases and controls recall exposures. For example, those 
diagnosed with T1D may be more cognizant of exposures they had than those not 
diagnosed with T1D, which may cause a difference in the accuracy of the reported 
exposures by case status. To minimize this potential bias, the present study limited its 
population to individuals diagnosed with persistent, confirmed IA and T1D after 9 months 
of age to ensure that exposure data was collected prior to determination of either 
outcome. Additionally, the recall of animal exposure in this study was only for a period of 
9 months; whereas, the other referenced case-control studies required recall for a period 
of many years.  
 This study is further strengthened by its use of propensity scores and multiple 
propensity score techniques. By comparing exposed and unexposed participants with 
similar propensity scores, one is simulating a random allocation of treatment. The 
propensity score is intended to capture all the background characteristics of the 
participant; therefore, if an exposed participant and unexposed participant have the 
same propensity score, it is expected that the only difference between these participants 
in regard to risk for the endpoint would be the exposure of interest, early life animal 
exposure. This simulation of random allocation helps to minimize any selection bias in 
regard to differences in the characteristics of the treatment (exposed and unexposed) 
groups (27, 28). Initially, propensity score analysis was applied by adjusting for 
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propensity score in the Cox proportional hazards models. While this method allows one 
to explore the association between early life animal exposure and the endpoints of 
interest while controlling for confounding, it does not allow one to explore how 
confounding and distribution of variables play a role across the propensity score range. 
Therefore, quintiles on propensity score were created in order to further explore the 
association in this regard. The third propensity score application, propensity score pair 
matching, was pursued in order to define highly matched participants on propensity 
score to tease out any effect between early life animal exposure and the outcomes of 
interest. 
Stratification on propensity score brought to light a few variables that appear to 
drive propensity for early life animal exposure, including crowding (residence density), 
residence type (e.g., rural), and country of residence. For instance, the group with the 
lowest predicted probability of early life animal exposure (quintile 1) included a higher 
proportion (17%) of participants living in a crowded environment than the other quintiles. 
Furthermore, the group with the lowest propensity for early life animal exposure (quintile 
1) included no participants who lived in rural areas; whereas, 50% of the participants in 
the group with the highest propensity for early life animal exposure (quintile 5) lived in 
rural areas. The most striking difference between quintiles was in regard to the 
distribution of country of residence, which largely characterized each quintile. Quintile 1 
included mostly participants from Finland (73%), quintile 2 included mostly participants 
from Sweden (75%), and quintiles 4 and 5 included mostly participants from the U.S. 
(90% and 72% respectively). Quintile 3 was a more heterogeneous population in terms 
of country of residence than the other quintiles; however, it still was largely characterized 
by participants residing in the U.S. (41%) and Sweden (33%) compared to Germany 
(13%) and Finland (13%).  These findings emphasized the need for consideration of 
potential interactions between early life animal exposure and these variables; however, 
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no significant interactions were found. Further research on the effect of crowding, 
residence type, and country of residence on animal exposure, IA, and T1D is warranted. 
It was hypothesized that this study would find that children exposed to animals in 
early life would have a lower risk of developing IA and T1D than children not exposed to 
animals in early life. This hypothesis was based on the idea, rooted in the hygiene 
hypothesis, that animals would increase a child’s exposure to organisms that help to 
develop appropriate immunoregulation; thus, minimizing the risk of a later immune 
system disregulation triggering the development of IA and T1D. The results of this study 
do not support the originally stated hypothesis.  
 While an overall difference in risk of T1D and persistent, confirmed IA by early 
life animal exposure status was not found in this study, additional research is needed to 
definitively rule out any potential role of animal exposure in the development of T1D. 
Suggested research questions include the effect of exposure to different types of 
animals, animal exposure duration, primary pet residence (e.g., exposure to family pets 
who live inside the home versus exposure to family pets who live outside the home), and 
exposure to animals outside the child’s residence (e.g., animals at the zoo, animals the 
child visits at another residence) on T1D and IA risk. Studies on animal exposure in 
crowded environments are also recommended in order to discern whether the overload 
hypothesis, which suggests that individuals who experience an overload of the islet cells 
in early life due to characteristics such as physical and psychological stress may result in 
accelerated islet autoimmunity and cell death (18, 29), applies to the relationship 
between early life animal exposure and T1D development. Additionally, the collection of 
data on differences in perceptions of pets across countries could aid the interpretation of 
studies on animal exposure and health outcomes.   
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Appendix 1 
The TEDDY Study Group 
 
Colorado Clinical Center: Marian Rewers, M.D., Ph.D., PI1,4,6,10,11, Katherine Barriga12, 
Kimberly Bautista12, Judith Baxter9,12,15, George Eisenbarth, M.D., Ph.D., Nicole Frank2, 
Patricia Gesualdo2,6,12,14,15, Michelle Hoffman12,13,14, Lisa Ide, Rachel Karban12, Edwin 
Liu, M.D.13, Jill Norris, Ph.D.2,3,12, Kathleen Waugh7,12,15 Adela Samper-Imaz, Andrea 
Steck, M.D.3, University of Colorado, Anschutz Medical Campus, Barbara Davis Center 
for Childhood Diabetes. 
 
Georgia/Florida Clinical Center: Jin-Xiong She, Ph.D.,PI1,3,4,11,†, Desmond Schatz, 
M.D.*4,5,7,8, Diane Hopkins12, Leigh Steed12,13,14,15, Jamie Thomas*6,12, Katherine Silvis2, 
Michael Haller, M.D.*14, Meena Shankar*2, Melissa Gardiner, Richard McIndoe, Ph.D., 
Haitao Liu, M.D.†, John Nechtman†, Ashok Sharma, Joshua Williams, Gabriela Foghis, 
Stephen W. Anderson, M.D.^  Medical College of Georgia, Georgia Regents University, 
*University of Florida, †Jinfiniti Biosciences LLC, Augusta, GA, ^Pediatric Endocrine 
Associates, Atlanta, GA. 
 
Germany Clinical Center: Anette G. Ziegler  M.D.,PI1,3,4,11,  Andreas Beyerlein Ph.D.2, 
Ezio Bonifacio Ph.D.*5,  Lydia Henneberger2,12, Michael Hummel M.D.13, Sandra 
Hummel Ph.D.2, Kristina Foterek¥2, Mathilde Kersting Ph.D.¥2, Annette Knopff7, Sibylle 
Koletzko, M.D.¶13, Stephanie Krause, Claudia Peplow12, Maren Pflüger Ph.D.6, Roswith 
Roth Ph.D.9, Julia Schenkel2,12, Joanna Stock9,12,  Elisabeth Strauss12, Katharina 
Warncke M.D.14, Christiane Winkler Ph.D.2,12,15,  Forschergruppe Diabetes e.V. at 
Helmholtz Zentrum München, *Center for Regenerative Therapies, TU Dresden, ¶Dr. von 
Hauner Children´s Hospital,Department of Gastroenterology, Ludwig Maximillians 
University Munich,  ¥Research Institute for Child Nutrition, Dortmund. 
 
Finland Clinical Center: Olli G. Simell, M.D., Ph.D.,PI¥^1,4,11,13, Heikki Hyöty, M.D., 
Ph.D.*±6, Jorma Ilonen, M.D., Ph.D.¥ ¶3, Mikael Knip, M.D., Ph.D.*±, Maria Lönnrot, M.D., 
Ph.D.*±6, Elina Mantymaki¥^, Juha Mykkänen, Ph.D.^¥ 3, Kirsti Nanto-Salonen, M.D., 
Ph.D.¥ ^12, Tiina Niininen±*12, Mia Nyblom*±, Anne Riikonen*±2, Minna Romo¥^, Barbara 
Simell¥^9,12,15, Tuula Simell, Ph.D.¥^9,12, Ville Simell^¥13,  Maija Sjöberg¥^12,14, Aino 
Steniusµ¤12, Jorma Toppari, M.D., Ph.D., Eeva Varjonen¥^12, Riitta Veijola, M.D., Ph.D. 
µ¤14, Suvi M. Virtanen, M.D., Ph.D.*±§2. ¥University of Turku, *University of Tampere, 
µUniversity of Oulu, ^Turku University Hospital, ±Tampere University Hospital, ¤Oulu 
University Hospital, §National Institute for Health and Welfare, Finland, ¶University of 
Kuopio. 
 
Sweden Clinical Center: Åke Lernmark, Ph.D., PI1,3,4,5,6,8,10,11,15, Daniel Agardh, M.D., 
Ph.D.13, Carin Andrén-Aronsson2,13, Maria Ask, Jenny Bremer, Corrado Cilio Ph.D., 
M.D.5, Emilie Ericson-Hallström2, Lina Fransson, Thomas Gard, Joanna Gerardsson, 
Gertie Hansson12,14, Monica Hansen, Susanne Hyberg, Fredrik Johansen, Berglind 
Jonasdottir M.D., Ulla-Marie Karlsson, Helena Larsson M.D., Ph.D. 6,14,  Barbro 
Lernmark, Ph.D.9,12, Maria Markan, Theodosia Massadakis, Jessica Melin12, Maria 
Månsson-Martinez, Anita Nilsson, Kobra Rahmati, Monica Sedig Järvirova, Sara 
Sibthorpe, Birgitta Sjöberg, Ulrica Swartling, Ph.D. 9,12, Erika Trulsson, Carina Törn, 
Ph.D. 3,15, Anne Wallin, Åsa Wimar12, Sofie Åberg. Lund University. 
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Washington Clinical Center: William A. Hagopian, M.D., Ph.D., PI1,3,4, 5, 6,7,11,13, 14, Xiang 
Yan, M.D., Michael Killian6,7,12,13, Claire Cowen Crouch12,14,15, Kristen M. Hay2, Stephen 
Ayres, Carissa Adams, Brandi Bratrude, David Coughlin, Greer Fowler, Czarina Franco, 
Carla Hammar, Diana Heaney, Patrick Marcus, Arlene Meyer, Denise Mulenga, 
Elizabeth Scott, Jennifer Skidmore2, Joshua Stabbert, Viktoria Stepitova, Nancy 
Williams. Pacific Northwest Diabetes Research Institute. 
 
Pennsylvania Satellite Center: Dorothy Becker, M.D., Margaret Franciscus12, 
MaryEllen Dalmagro-Elias2, Ashi Daftary, M.D.  Children’s Hospital of Pittsburgh of 
UPMC. 
 
Data Coordinating Center: Jeffrey P. Krischer, Ph.D.,PI1,4,5,10,11, Michael 
Abbondondolo, Sarah Austin, Rasheedah Brown12,15, Brant Burkhardt, Ph.D.5,6, Martha 
Butterworth2, David Cuthbertson, Christopher Eberhard, Steven Fiske9, Veena Gowda, 
David Hadley, Ph.D.3,13, Hye-Seung Lee, Ph.D.3,6,13,15, Shu Liu, Kristian Lynch, Ph.D. 6,9, 
Jamie Malloy, Cristina McCarthy12,15, Wendy McLeod2,5,6,13,15, Laura Smith, Ph.D.9,12, 
Susan Smith12,15, Roy Tamura, Ph.D.2,  Ulla Uusitalo, Ph.D.2,15, Kendra Vehik, Ph.D. 
4,5,9,14,15, Earnest Washington, Jimin Yang, Ph.D., R.D.2,15. University of South Florida.  
 
Project scientist:  Beena Akolkar, Ph.D.1,3,4,5, 6,7,10,11, National Institutes of Diabetes and 
Digestive and Kidney Diseases. 
 
Other contributors: Kasia Bourcier, Ph.D.5, National Institutes of Allergy and Infectious 
Diseases. Thomas Briese, Ph.D.6,15, Columbia University, Suzanne Bennett Johnson, 
Ph.D.9,12, Florida State University, Steve Oberste, Ph.D.6, Centers for Disease Control 
and Prevention, Eric Triplett, Ph.D. 6, University of Florida. 
 
Autoantibody Reference Laboratories: Liping Yu, M.D.^ 5, Dongmei Miao, M.D.^, Polly 
Bingley, M.D., FRCP*5, Alistair Williams*, Kyla Chandler*, Saba Rokni*, Anna Long 
Ph.D.*, Joanna Boldison*, Jacob Butterly*, Jessica Broadhurst*, Gabriella Carreno*, 
Rachel Curnock*, Peter Easton*, Ivey Geoghan*, Julia Goode*, James Pearson*, 
Charles Reed*, Sophie Ridewood*, Rebecca Wyatt*. ^Barbara Davis Center for 
Childhood Diabetes, University of Colorado Denver, *School of Clinical Sciences, 
University of Bristol UK. 
 
Cortisol Laboratory: Elisabeth Aardal Eriksson, M.D., Ph.D., Ewa Lönn Karlsson. 
Department of Clinical Chemistry, Linköping University Hospital, Linköping, Sweden. 
 
Dietary Biomarkers Laboratory: Iris Erlund, Ph.D.2, Irma Salminen, Jouko Sundvall, 
Jaana Leiviskä, Mari Lehtonen, Ph.D. National Institute for Health and Welfare, Helsinki, 
Finland. 
 
HbA1c Laboratory: Randie R. Little, Ph.D., Alethea L. Tennill. Diabetes Diagnostic 
Laboratory, Dept. of Pathology, University of Missouri School of Medicine. 
 
HLA Reference Laboratory: Henry Erlich, Ph.D.3, Teodorica Bugawan, Maria 
Alejandrino.  Department of Human Genetics, Roche Molecular Systems. 
 
Metabolomics Laboratory: Oliver Fiehn, Ph.D., Bill Wikoff, Ph.D., Tobias Kind, Ph.D., 
Mine Palazoglu, Joyce Wong, Gert Wohlgemuth. UC Davis Metabolomics Center. 
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Microbiome and Viral Metagenomics Laboratory: Joseph F. Petrosino, Ph.D.6 Alkek 
Center for Metagenomics and Microbiome Research, Department of Molecular Virology 
and Microbiology, Baylor College of Medicine. 
 
OGTT Laboratory: Santica M. Marcovina, Ph.D., Sc.D. Northwest Lipid Metabolism and 
Diabetes Research Laboratories, University of Washington. 
 
Repository: Heather Higgins, Sandra Ke.  NIDDK Biosample Repository at Fisher 
BioServices. 
 
RNA Laboratory and Gene Expression Laboratory: Jin-Xiong She, Ph.D.,PI1,3,4,11, 
Richard McIndoe, Ph.D., Haitao Liu, M.D., John Nechtman, Yansheng Zhao, Na Jiang, 
M.D. Jinfiniti Biosciences, LLC.  
 
SNP Laboratory: Stephen S. Rich, Ph.D.3, Wei-Min Chen, Ph.D.3, Suna Onengut-
Gumuscu, Ph.D.3, Emily Farber, Rebecca Roche Pickin, Ph.D., Jordan Davis, Dan Gallo. 
Center for Public Health Genomics, University of Virginia. 
 
 
Committees: 
1Ancillary Studies, 2Diet, 3Genetics, 4Human Subjects/Publicity/Publications, 5Immune 
Markers, 6Infectious Agents, 7Laboratory Implementation, 8Maternal Studies, 
9Psychosocial, 10Quality Assurance, 11Steering, 12Study Coordinators, 13Celiac Disease, 
14Clinical Implementation, 15Quality Assurance Subcommittee on Data Quality. 
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Appendix 2 
The TEDDY study forms utilized to collect data on early life animal exposures and T1D 
diagnosis are provided on the following pages. 
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 Appendix 3 
The assumptions of the Cox proportional hazards model were explored by 
randomly simulating 1000 empirical score processes, based on martingale residuals, 
that meet the proportional hazards assumption for the variable early life animal exposure 
in regard to each outcome of interest (IA and T1D) and then calculating a p-value 
representing the percent of simulated paths that had extreme points that exceeded the 
most extreme point of the observed path for the variable of interest. A p-value less than 
0.05 would be evidence against the proportional hazards assumption. The resulting p-
values for each predictor variable are summarized in Table A1 for the outcome 
persistent, confirmed IA and in Table A2 for the outcome T1D.  
All p-values produced by the models for the association between early life animal 
exposure and persistent, confirmed IA were greater than the significance level of 0.05; 
therefore, the proportional hazards assumption is supported. All p-values produced by 
the models for the association between early life animal exposure and T1D were greater 
than the significance level of 0.05; therefore, the proportional hazards assumption is 
supported.  
 
Table A1: Test for Proportional Hazards Assumption, P-values for each variable included 
in model, H0: Hazards Proportional; alpha = 0.05, IA Outcome 
 Model1 
Variable Unadjusted Model 
P-value 
Adjusted Model 1 
P-value 
Adjusted Model 2  
P-value 
Animal 
Exposure 0.6570 0.6410 0.6470 
Propensity 
Score  0.2250 0.1920 
HLA DQ2/2   0.3900 
HLA DQ8/2   0.6830 
HLA DQ8/4   0.5870 
Other HLA   0.7190 
1 The unadjusted model includes early life animal exposure only (reference group unexposed). 
Adjusted model 1 is adjusted for early life animal exposure propensity score. Adjusted model 2 is 
adjusted for propensity score and HLA (reference group DQ8/8).  
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Table A2: Test for Proportional Hazards Assumption, P-values for each variable included 
in model, H0: Hazards Proportional; alpha = 0.05, T1D Outcome 
 Model1 
Variable Unadjusted Model 
P-value 
Adjusted Model 1 
P-value 
Adjusted Model 2 
P-value 
Animal 
Exposure 
0.6690 0.5230 0.5380 
Propensity 
Score 
 0.0800 0.0930 
HLA DQ2/2   0.5480 
HLA DQ8/2   0.5870 
HLA DQ8/4   0.2410 
Other HLA   0.6760 
1 The unadjusted model includes early life animal exposure only (reference group unexposed). 
Adjusted model 1 is adjusted for early life animal exposure propensity score. Adjusted model 2 is 
adjusted for propensity score and HLA (reference group DQ8/8).  
 
 
Additionally, the first 20 simulated paths and the actual path for early life animal 
exposure were plotted for outcome persistent, confirmed IA (Figure A1) and T1D (Figure 
A2). The actual paths do not vary drastically from the simulated paths. This is evidence 
in support of the proportional hazards assumption. 
 
  
Figure A1: Checking Proportional Hazards Assumption for Early Life Animal Exposure 
Variable, Outcome Persistent, Confirmed IA, Unadjusted Model 
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Figure A2: Checking Proportional Hazards Assumption for Early Life Animal Exposure 
Variable, Outcome T1D, Unadjusted Model 
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Appendix 4 
The Environmental Determinants of Diabetes in the Young (TEDDY) study is approved 
by the University of South Florida Institutional Review Board (IRB). The IRB approval for 
Callyn Hall, author of this thesis, to conduct analyses on the TEDDY study data is 
provided on the following page. 
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